# Chapter 45: Trichotillomania (Hair-Pulling Disorder)

Here is the comprehensive academic chapter on the biological and neurological basis of Trichotillomania, citing exclusively from the provided research papers.

# The Biological and Neurological Basis of Trichotillomania (Hair-Pulling Disorder)

## Introduction

Trichotillomania (TTM), also known as Hair-Pulling Disorder, is a complex and often debilitating condition characterized by the recurrent, irresistible urge to pull out one's own hair, resulting in noticeable hair loss and significant psychosocial impairment (Walther & Woods, 2010; Schreiber et al., 2011; Huynh et al., 2013). Historically conceptualized and classified as an Impulse-Control Disorder (Walther & Woods, 2010; Adams & Jones, 1998; Pacan et al., 1999), its position within psychiatric nosology has evolved. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) now categorizes TTM under "Obsessive-Compulsive and Related Disorders" (OCRDs), highlighting its phenomenological and potential etiological overlap with conditions such as Obsessive-Compulsive Disorder (OCD) (Kakunje & Rao, 2017; ROY et al., 2022; Phillips & Stein, 2015; Sheikh & Godil, 2024). This reclassification reflects a growing understanding that TTM is not merely a "bad habit" but a neuropsychiatric disorder with substantial biological underpinnings (Grant & Chamberlain, 2021; O’Sullivan et al., 1997).

The pathology of TTM spans both neurological and psychosocial domains (O’Sullivan et al., 1997). While behavioral models have traditionally emphasized the roles of tension and relief (Walther & Woods, 2010) and sensory reinforcement (Kakunje & Rao, 2017), a comprehensive understanding of TTM requires an in-depth exploration of its neurobiological substrates. The disorder's etiology is considered multifactorial, involving a complex interplay between genetic predispositions, neurochemical imbalances, structural and functional brain abnormalities, and environmental stressors (Schreiber et al., 2011; Akaltun, 2019). The significant psychiatric comorbidity, particularly with mood and anxiety disorders (Anwar & Jafferany, 2019; Christenson & Crow, 1996; Grant & Chamberlain, 2021), further suggests shared or overlapping neurobiological pathways. For instance, high rates of co-occurring depression and anxiety are frequently reported in individuals with TTM, complicating both the clinical picture and the etiological investigation (ROY et al., 2022; Annagür, 2010; Diaz, 2015).

Emerging research utilizing neuroimaging, neuropharmacology, and genetic analyses has begun to illuminate the specific biological mechanisms that may drive the urge-driven, repetitive nature of hair pulling (Schreiber et al., 2011; Chamberlain, 2012). This brain-based perspective moves beyond a purely psychological or behavioral conceptualization, viewing TTM as a disorder of affect regulation, habit formation, and impulse control rooted in observable neural processes (Chamberlain, 2012; Stein et al., 2006). This chapter aims to synthesize the current, albeit incomplete, state of knowledge regarding the biological and neurological basis of Trichotillomania. By examining implicated neurotransmitter systems, neural circuits, genetic factors, and neuroimaging findings, we can construct a more integrated biopsychosocial model of the disorder. This model is not only crucial for advancing our fundamental understanding of TTM but also for guiding the development of more targeted and effective therapeutic interventions, both pharmacological and non-pharmacological (Franklin et al., 2011; Jafferany et al., 2020). Acknowledging the neurobiological foundations of TTM is a critical step in reducing stigma and improving care for the millions affected by this underrecognized and often hidden condition (Löchner et al., 2017; Jefferys, 1995).

## Neurobiological Systems

The neurobiological investigation of Trichotillomania has increasingly focused on the complex interplay of neurotransmitter systems and the neural circuits they modulate. While our understanding remains limited (Akaltun, 2019), evidence from neuropharmacological trials, animal models, and clinical phenomenology points toward the dysregulation of several key systems, primarily involving serotonin, dopamine, and glutamate (Schreiber et al., 2011; Christenson & Crow, 1996). These systems are fundamental to mood, reward, habit formation, and executive control—domains that are critically implicated in the pathophysiology of TTM (Chamberlain, 2012).

### Neurotransmitter Systems and Neuropharmacology

Pharmacological interventions provide an indirect but valuable window into the neurochemical underpinnings of TTM. The variable success of drugs targeting specific neurotransmitters suggests a heterogeneous and complex neurobiology rather than a single chemical imbalance (Franklin et al., 2011; Nemeczek et al., 2023).

#### The Serotonergic System

Historically, the serotonergic system has been a primary focus of investigation, largely due to TTM's phenomenological overlap and classification with OCD (Christenson & Crow, 1996; Stein et al., 1995; Sharquie & Al-Jaralla, 2020). Both the tricyclic antidepressant clomipramine, a potent serotonin reuptake inhibitor, and the class of selective serotonin reuptake inhibitors (SSRIs) have been widely studied and prescribed (Christenson & Crow, 1996; Franklin et al., 2011; Huynh et al., 2013). Clomipramine has demonstrated some efficacy in clinical trials (Franklin et al., 2011; Slagle & Martin, 1991; Nemeczek et al., 2023).

However, the role of serotonin is far from straightforward. Multiple reviews and studies indicate that SSRIs (e.g., fluoxetine, sertraline, paroxetine), which are first-line treatments for OCD, appear largely ineffective for TTM (Grant, 2019; Franklin et al., 2011; Ghani et al., 2024). This therapeutic divergence suggests that while TTM shares features with OCD, its underlying neurobiology is distinct (Grant, 2019; Stein et al., 1995). The limited efficacy of SSRIs has led some to question the centrality of the serotonin deficit hypothesis in TTM (Shoenfeld et al., 2012). Paradoxically, there are case reports of SSRIs, such as fluoxetine and paroxetine, potentially inducing or exacerbating TTM symptoms (Yektaş & Tufan, 2017; Bolat & Yavuz, 2016; Zalsman et al., 1999). One hypothesis for this effect is that SSRIs may have facilitative effects on dopamine, thereby increasing impulsive behaviors (Bolat & Yavuz, 2016). These findings underscore that the serotonergic system's involvement is likely complex, perhaps modulating other primary systems rather than being the core driver of the disorder.

#### The Glutamatergic System

Growing evidence points to the glutamate system as a key player in the pathophysiology of TTM and other compulsive behaviors (Erşan, 2013). Glutamate is the brain's primary excitatory neurotransmitter, and its dysregulation is implicated in disorders of compulsivity and addiction (Chamberlain, 2012). The most significant pharmacological development supporting this hypothesis is the promising effect of N-acetylcysteine (NAC), a glutamate-modulating agent (Schreiber et al., 2011; Grant & Chamberlain, 2021). NAC, an antioxidant and precursor to glutathione, is believed to modulate synaptic glutamate release (Erşan, 2013). Several reports and reviews have highlighted the potential utility of NAC in reducing hair-pulling symptoms, suggesting it may be a helpful intervention (Grant, 2019; Schreiber et al., 2011; Grant & Chamberlain, 2015; Zhao et al., 2021; Kılıç & Keleş, 2018; Cisoń et al., 2018; Ghani et al., 2024). The effectiveness of NAC suggests that TTM may share a common pathophysiological mechanism with other impulse control disorders where glutamatergic agents have shown benefit (Zhao et al., 2021; Erşan, 2013). Further support for this pathway comes from a case report showing beneficial effects of riluzole, another antiglutamatergic agent, in a patient with TTM (Coric et al., 2007). The focus on glutamate represents a significant shift in the neurobiological conceptualization of TTM, moving toward models of cortical-striatal-thalamic-cortical (CSTC) circuit dysregulation common in OCRDs.

#### The Dopaminergic System

The dopaminergic system, critically involved in reward, motivation, and motor control, is also implicated in TTM, particularly in relation to its impulsive and habit-like features (Stein et al., 1995; Chamberlain, 2012). The pleasure, gratification, or relief experienced after pulling provides a powerful reinforcement mechanism that may be mediated by dopamine release (Walther & Woods, 2010; Kakunje & Rao, 2017). Some conceptualize TTM as having features of an addictive disorder, which strongly implicates dopaminergic reward pathways (Witkowski et al., 2010; Shoenfeld et al., 2012).

Pharmacological evidence supports this link. Atypical antipsychotics, which primarily act as dopamine (and serotonin) receptor antagonists, have shown some efficacy. In particular, olanzapine has been noted as a potentially helpful medication for TTM (Grant, 2019; Schreiber et al., 2011; Grant & Chamberlain, 2021). The use of bupropion, a norepinephrine-dopamine reuptake inhibitor, has also been reported to be effective in a case of fluoxetine-nonresponsive TTM, suggesting that modulation of the mesolimbic dopamine pathway may be beneficial (Bipeta & Yerramilli, 2011). Furthermore, case reports have linked atomoxetine, a norepinephrine reuptake inhibitor that can indirectly affect dopamine levels, to the emergence of TTM symptoms, possibly by increasing dopamine in mesolimbic pathways and facilitating hair-pulling behavior (Ayaydın, 2018; Bolat & Yavuz, 2016). This converging evidence suggests that dysregulation in dopaminergic circuits governing habit formation and reward processing is a significant component of TTM's neurobiology.

### Neural Circuits and Functional Connectivity

While specific neuroimaging data from the provided sources are limited, a brain-based model of TTM can be formulated based on its classification, phenomenology, and response to neuromodulatory treatments (Chamberlain, 2012). TTM is increasingly understood not as a disorder of a single brain region or neurotransmitter, but as a dysfunction within large-scale neural circuits responsible for emotional regulation, habit formation, and cognitive control (Chamberlain, 2012).

The classification of TTM within the OCRD spectrum strongly suggests the involvement of cortico-striato-thalamo-cortical (CSTC) loops (Löchner et al., 2017). These circuits, which link the prefrontal cortex, basal ganglia (striatum), and thalamus, are central to mediating obsessive thoughts and compulsive behaviors (Cybulska, 2006). In TTM, dysfunction within these loops could manifest as an inability to inhibit the prepotent urge to pull (impulse dyscontrol) and the subsequent automation of the pulling behavior into a deeply ingrained habit (Chamberlain, 2012; Stein et al., 2006). The efficacy of glutamate modulators like NAC further supports the CSTC model, as glutamate is the principal neurotransmitter in these pathways (Erşan, 2013).

Chamberlain (2012) proposed a brain-based model for TTM centered on three interacting domains: affect dysregulation, addiction, and impulse dyscontrol. This model implicates a network of brain regions:
1.  **Affect Dysregulation:** Many pulling episodes are triggered by negative emotional states such as stress, anxiety, or boredom (Schreiber et al., 2011; Kakunje & Rao, 2017). The hair-pulling behavior may function to provide short-term relief from these unwanted states, serving as a maladaptive emotion regulation strategy (Anwar & Jafferany, 2019). This implicates limbic structures like the amygdala and anterior cingulate cortex, which are involved in processing and regulating emotion.
2.  **Addiction/Habit Formation:** The repetitive, stereotyped nature of hair pulling, often performed automatically without full awareness, resembles habit-based behaviors mediated by the dorsal striatum (a key part of the basal ganglia) (Stein et al., 2006). The sense of pleasure or relief following the act serves as a positive reinforcement, strengthening the habit loop, a process in which the ventral striatum and its dopaminergic inputs play a crucial role (Shoenfeld et al., 2012).
3.  **Impulse Dyscontrol:** The core diagnostic feature of failing to resist the urge to pull (Walther & Woods, 2010) points to deficits in top-down inhibitory control. This function is primarily managed by regions of the prefrontal cortex (PFC), such as the orbitofrontal cortex and dorsolateral PFC. Impaired connectivity between the PFC and the striatum could lead to a failure to suppress unwanted urges generated in subcortical structures (Chamberlain, 2012).

Animal models, such as those involving excessive grooming in rodents, have been developed to investigate these mechanisms and provide further evidence for the involvement of these circuits (Schreiber et al., 2011; Mackay, 2023). While these models are simplifications, they support the hypothesis that TTM arises from a pathological dysregulation within evolutionarily conserved grooming circuits, which are modulated by the neurobiological systems of emotion, habit, and cognitive control.

## Genetic and Molecular Basis

The etiology of Trichotillomania is understood to be a complex interplay of multiple factors, with a growing appreciation for the role of genetic and molecular mechanisms (Schreiber et al., 2011; Akaltun, 2019). Although the precise genetic architecture of TTM remains to be fully elucidated, evidence from family studies and the disorder's association with other heritable psychiatric conditions suggest a significant genetic underpinning (Löchner et al., 2017). This predisposition likely involves multiple genes interacting with psychological and environmental influences to produce the clinical phenotype (Akaltun, 2019).

### Heritability and Familial Aggregation

Clinical observations and systematic studies have noted that TTM can run in families, suggesting a heritable component (Franklin et al., 2011). The disorder's place within the obsessive-compulsive and related disorders (OCRD) spectrum is relevant, as conditions like OCD have a well-documented genetic basis (Löchner et al., 2017; Christenson & Crow, 1996). The increased incidence of comorbid OCD in TTM patients (Christenson & Crow, 1996) may point to a shared genetic vulnerability between these disorders. Similarly, the frequent co-occurrence of other body-focused repetitive behaviors (BFRBs) such as skin-picking (dermatillomania) and nail-biting (onychophagia) in individuals with TTM and their relatives suggests a potential shared genetic diathesis for these behaviors (Perman, 2024; Grant & Chamberlain, 2021; Siddiqui & Qureshi, 2018).

The exploration of genetics as a key etiological factor is a recognized avenue of research in understanding TTM (Schreiber et al., 2011). However, the pattern of inheritance is not straightforward, indicating that TTM is not a simple Mendelian disorder but rather a complex genetic condition where multiple genes of small effect likely contribute to overall risk (Löchner et al., 2017). This genetic complexity is typical for most neuropsychiatric disorders (Grant & Chamberlain, 2021). The search for specific candidate genes and molecular pathways is ongoing, with research often paralleling investigations into the neurobiology of OCD and other related conditions (Christenson & Crow, 1996).

### Candidate Genes and Molecular Pathways

While the provided literature does not specify particular genes identified in large-scale association studies for TTM, we can infer potential molecular pathways based on the neuropharmacological evidence. The neurotransmitter systems most strongly implicated in TTM—glutamate, dopamine, and serotonin—are regulated by a host of genes that code for receptors, transporters, and metabolic enzymes. These genes represent logical candidates for investigation.

1.  **Glutamatergic Pathways:** The promising therapeutic effects of N-acetylcysteine (NAC), a glutamate modulator, strongly suggest that genes involved in glutamatergic neurotransmission may play a role in TTM susceptibility (Erşan, 2013; Grant, 2019). This could include genes for glutamate transporters (which regulate synaptic glutamate levels) or for various subunits of NMDA and AMPA glutamate receptors, which mediate excitatory signaling in cortico-striatal circuits (Coric et al., 2007). Dysfunction in these pathways could lead to the kind of circuit-level hyperexcitability thought to underlie compulsive behaviors (Stein et al., 2006).

2.  **Dopaminergic Pathways:** Given the role of dopamine in reward, habit formation, and impulse control, genes related to the dopaminergic system are also strong candidates (Shoenfeld et al., 2012). These might include genes for dopamine receptors (e.g., D2, D3, D4) and the dopamine transporter (DAT). Variations in these genes could influence an individual's sensitivity to the reinforcing effects of hair pulling and their ability to inhibit the urge to perform the behavior (Bipeta & Yerramilli, 2011). The link between atomoxetine and TTM symptoms further points to catecholamine system involvement (Ayaydın, 2018).

3.  **Serotonergic Pathways:** Despite the mixed results for SSRIs in treating TTM, the serotonergic system cannot be entirely dismissed, especially given the efficacy of clomipramine and the disorder's relationship with OCD (Franklin et al., 2011; Christenson & Crow, 1996). Genes for the serotonin transporter (SERT, the target of SSRIs) and various serotonin receptors could contribute to a vulnerability profile, perhaps by modulating downstream dopaminergic or glutamatergic activity (Bolat & Yavuz, 2016).

### Other Molecular and Cellular Mechanisms

Beyond classical neurotransmitter systems, other molecular factors may be involved. The mention of Vitamin D deficiency as a potential trigger in a pediatric case of TTM suggests that factors influencing neurodevelopment and cellular health could be relevant (Akaltun, 2019). Vitamin D is known to have roles in neuro-immunomodulation and the regulation of neurotrophic factors, which are crucial for neuronal survival and plasticity (Akaltun, 2019). While this is an isolated observation, it aligns with the broader view that TTM is a complex disorder influenced by a wide range of biological factors (Akaltun, 2019).

Furthermore, animal models of excessive grooming, which mirror the pathological behavior in TTM, provide a platform for exploring underlying molecular mechanisms (Schreiber et al., 2011; Mackay, 2023). Some theories suggest that these behaviors may relate to dysregulated immune-system-mediated feedback loops, which could involve molecular signals like cytokines (Mackay, 2023). While speculative, this highlights the potential for novel molecular pathways beyond traditional neurotransmission to be involved in the pathogenesis of BFRBs.

In summary, the genetic basis of TTM is likely polygenic and complex, involving interactions between multiple genes and environmental factors (Akaltun, 2019). Current evidence, primarily from pharmacology, points toward genes regulating the glutamate, dopamine, and serotonin systems as important areas for future molecular research. A deeper understanding of these genetic and molecular underpinnings is essential for elucidating the pathophysiology of the disorder and for the development of novel, mechanism-based treatments (Torales et al., 2020).

## Brain Structure and Function

Neuroimaging studies have begun to provide crucial insights into the neuroanatomical basis of Trichotillomania, moving the field toward a circuit-based understanding of the disorder (Schreiber et al., 2011). While the body of research is still developing, findings from structural and functional neuroimaging are starting to delineate a network of brain regions whose altered morphology and activity may underlie the core symptoms of TTM, such as impaired impulse control, aberrant habit formation, and emotional dysregulation (Chamberlain, 2012). These studies provide evidence that several specific brain regions may be involved in the pathophysiology of TTM (Schreiber et al., 2011).

### Structural Neuroimaging Findings

Structural magnetic resonance imaging (sMRI) allows for the examination of brain morphology, including the volume, thickness, and density of gray matter in various cortical and subcortical regions. Although the provided literature offers a high-level summary rather than detailing specific sMRI studies, it consistently notes that such investigations have provided evidence for brain alterations in TTM (Schreiber et al., 2011; Chamberlain, 2012).

Based on the conceptualization of TTM as a disorder of impulse control and habit, key regions of interest for structural studies include the prefrontal cortex (PFC), the basal ganglia (particularly the striatum), and limbic structures like the amygdala and hippocampus.
*   **Prefrontal Cortex (PFC):** Areas within the PFC, such as the orbitofrontal cortex (OFC) and anterior cingulate cortex (ACC), are critical for top-down inhibitory control and emotional regulation. Structural abnormalities in these regions could plausibly lead to an inability to suppress the urge to pull hair (Chamberlain, 2012).
*   **Basal Ganglia:** The striatum (comprising the caudate and putamen) is a central hub for habit learning. Alterations in the volume or density of these regions could reflect the neuroplastic changes associated with the formation of the deeply ingrained motor habit of hair pulling (Stein et al., 2006).
*   **Limbic System:** The hippocampus and amygdala are key to memory and emotion processing. Given that stress and negative affective states often trigger pulling episodes (Anwar & Jafferany, 2019), structural changes in these areas might reflect a heightened sensitivity to emotional triggers or altered emotional memory consolidation. Indeed, stress is known to cause atrophy of hippocampal neurons, and such changes have been observed in patients with recurrent major depression, a common comorbidity in TTM (Vaidya et al., 1999; Carney & Freedland, 2000).

The use of neuroimaging probes is a salient feature of modern research into TTM (Chamberlain, 2012), and these structural studies are beginning to build a picture of a distributed network of anatomical differences that distinguish individuals with TTM from healthy controls.

### Functional Neuroimaging Findings

Functional neuroimaging techniques, such as functional magnetic resonance imaging (fMRI), allow researchers to investigate brain activity and connectivity during specific tasks or in a resting state. These studies offer a dynamic view of the neural processes associated with TTM symptoms. Again, while specific study details are not provided in the source material, the literature confirms that functional brain imaging has implicated several key regions (Schreiber et al., 2011).

A central hypothesis in OCRDs is the dysregulation of cortico-striato-thalamo-cortical (CSTC) circuits (Löchner et al., 2017). Functional imaging studies in related disorders like OCD have shown hyperactivity in regions like the OFC, ACC, and caudate nucleus, which often normalizes with successful treatment (Cybulska, 2006). It is plausible that similar, or perhaps distinct, patterns of CSTC dysregulation are present in TTM. For example, functional imaging could reveal:
*   **Hyperactivity in Urge-Related Regions:** During moments of craving or tension before pulling, there might be heightened activity in limbic and striatal regions associated with reward-seeking and emotion, reflecting the build-up of the urge (Chamberlain, 2012).
*   **Hypoactivity in Inhibitory Regions:** When attempting to resist the urge to pull, individuals with TTM might show insufficient activation in prefrontal control regions (e.g., dorsolateral PFC, inferior frontal gyrus), indicating a failure of top-down inhibitory signaling (Chamberlain, 2012).
*   **Altered Connectivity:** The communication and synchronization of activity between brain regions may be altered. For example, weakened functional connectivity between prefrontal control centers and subcortical habit/emotion centers could be a core deficit, leading to a breakdown in self-regulation.

The brain-based model proposed by Chamberlain (2012), emphasizing deficits in affect regulation, impulse control, and addiction, provides a useful framework for interpreting these functional findings. The subjective experience of an increasing sense of tension before pulling and pleasure or relief afterward (Walther & Woods, 2010) likely has direct correlates in the dynamic activity of these interconnected neural systems. For instance, the relief from an unwanted emotional state (Anwar & Jafferany, 2019) could be reflected in a dampening of amygdala activity post-pull, reinforcing the behavior through negative reinforcement.

In conclusion, while the specific patterns are still being mapped, neuroimaging studies collectively support the view of TTM as a brain disorder. Both structural and functional abnormalities have been identified in a network of regions crucial for emotion regulation, habit learning, and cognitive control (Schreiber et al., 2011; Chamberlain, 2012). Future research using more advanced imaging techniques will be essential to refine these models, identify potential biological subtypes of TTM, and develop neuromodulatory treatments that can target these dysfunctional circuits directly.

## Developmental Neurobiology

Trichotillomania typically emerges during sensitive developmental periods, with onset most commonly occurring in late childhood or early adolescence (Kakunje & Rao, 2017; Christenson & Crow, 1996). This specific timing suggests that the neurobiological mechanisms underlying TTM may be closely linked to the dynamic processes of brain development, maturation, and plasticity that characterize these life stages (Franklin et al., 2011). Understanding the disorder from a developmental neurobiology perspective is crucial for elucidating why vulnerability is heightened during these periods and for tailoring age-appropriate interventions.

### Age of Onset and Critical Periods

The literature consistently reports a bimodal or dual peak in the age of onset for TTM. The first peak occurs in early childhood, often before the age of six, while the second, and more common, peak occurs around puberty, with a mean age of onset between 9 and 13 years (ROY et al., 2022; Kakunje & Rao, 2017; Jafferany et al., 2020; Huynh et al., 2013). These two periods of onset may represent distinct developmental subtypes of the disorder with different underlying mechanisms and prognoses (Franklin et al., 2011).

Early-onset TTM, sometimes seen in preschool-aged children, is often considered a more benign, self-limiting habit, akin to thumb-sucking or nail-biting (Nguyen & Tharani, 2013; Perman, 2024). This form may be related to immature self-soothing mechanisms or transient developmental stress, such as separation anxiety (Fathi Nejad et al., 2015). From a neurobiological standpoint, this early period is marked by rapid synaptogenesis and the initial development of sensory-motor and emotional regulation circuits. The repetitive motor action of pulling may serve as a rudimentary strategy to modulate arousal or distress in a still-developing nervous system (Tiling, 1975).

In contrast, peri-pubertal or adolescent-onset TTM is typically more chronic, severe, and associated with greater psychiatric comorbidity, particularly depression and anxiety (Christenson & Crow, 1996; Franklin et al., 2011; Sheikh & Godil, 2024). Adolescence is a critical period of profound neurodevelopmental change, characterized by significant remodeling of key neural circuits, especially those involving the prefrontal cortex (PFC) and the limbic system (Sumiyoshi et al., 2012). The PFC, responsible for executive functions like impulse control and decision-making, matures more slowly than the subcortical limbic and striatal regions, which are involved in emotion and reward processing (Chamberlain, 2012). This developmental lag creates a period of heightened emotional reactivity and impulsivity, which may render adolescents particularly vulnerable to developing maladaptive coping behaviors like hair pulling (Anwar & Jafferany, 2019). Hormonal fluctuations during puberty also have significant effects on neurotransmitter systems and brain function, potentially interacting with genetic predispositions to trigger the onset of the disorder (Ross, 1951; Hirvonen, 1965).

### Neurodevelopmental Trajectories and Comorbidity

The onset of TTM during childhood and adolescence, when social identity and self-esteem are being formed, can have a profoundly negative impact on psychosocial development (Kakunje & Rao, 2017; Telegdy, 2009). The shame and embarrassment associated with hair loss often lead to social withdrawal and avoidance, which can disrupt the development of normal peer relationships (Anwar & Jafferany, 2019; Poot, 2004). This social isolation can, in turn, exacerbate feelings of anxiety and depression, creating a vicious cycle where pulling is used to cope with the very distress caused by the consequences of pulling (Mackay, 2023).

From a neurobiological perspective, this interaction between TTM and comorbid disorders is significant. Chronic stress, a hallmark of living with TTM, is known to have deleterious effects on brain structure and function, particularly on the hippocampus and amygdala, which are crucial for memory and emotion regulation (Schreiber et al., 2011; van Praag et al., 2004). The high rates of comorbid depression and anxiety disorders (Grant & Chamberlain, 2021; Christenson & Crow, 1996) suggest a shared underlying neurobiological vulnerability. For example, dysregulation in the hypothalamic-pituitary-adrenal (HPA) axis, the body's central stress response system, is a key feature of both depression and anxiety and could also play a role in triggering the urges to pull in TTM (Chamberlain, 2012).

Furthermore, TTM is often comorbid with other neurodevelopmental disorders, such as tic disorders and Tourette Syndrome (TS) (Roessner & Rothenberger, 2014; Erenberg, 1999). Tics, like hair pulling, are repetitive, semi-voluntary behaviors often preceded by a premonitory urge, suggesting a shared pathophysiology involving basal ganglia circuits (Leckman et al., 2002; Cavanna, 2020). The co-occurrence of these conditions points to a common neurodevelopmental pathway involving the maturation of motor control and inhibitory circuits. Genetic factors influencing the development of these fronto-striatal networks may confer a broad vulnerability to a spectrum of repetitive behavior disorders that manifest during childhood and adolescence (Löchner et al., 2017).

In conclusion, the typical age of onset for TTM strongly implicates neurodevelopmental processes in its etiology. The peri-pubertal period, with its dynamic changes in hormonal milieus and the asynchronous maturation of prefrontal and limbic brain circuits, appears to be a particularly critical window of vulnerability. Understanding these developmental factors is essential for early identification and for designing interventions that can interrupt the progression of the disorder before it becomes a chronic and deeply entrenched condition.

## Treatment Mechanisms

The treatment of Trichotillomania involves both pharmacological and psychotherapeutic approaches, each targeting the underlying neurobiological and behavioral mechanisms of the disorder from different angles (Franklin et al., 2011; Jafferany et al., 2020). An understanding of how these interventions work at a biological level is crucial for refining treatment strategies and developing novel therapies.

### Neurobiological Basis of Pharmacotherapy

Pharmacological treatments for TTM aim to correct presumed neurochemical imbalances within the brain circuits implicated in the disorder, primarily those involving glutamate, dopamine, and serotonin (Schreiber et al., 2011; Shoenfeld et al., 2012).

**Modulation of the Glutamatergic System:** The most promising recent advances in TTM pharmacotherapy have focused on the glutamatergic system (Grant, 2019). Agents such as N-acetylcysteine (NAC) are thought to exert their therapeutic effect by modulating glutamate transmission in corticostriatal pathways (Erşan, 2013). Excessive glutamate release in these circuits is hypothesized to contribute to compulsivity and an inability to inhibit prepotent urges (Stein et al., 2006). By restoring glutamate homeostasis, NAC may reduce the neurobiological drive underlying the compulsion to pull hair (Grant & Chamberlain, 2021; Kılıç & Keleş, 2018). This mechanism represents a direct intervention at the synaptic level within the habit and impulse control circuits believed to be dysfunctional in TTM (Erşan, 2013; Zhao et al., 2021). The potential efficacy of another antiglutamatergic agent, riluzole, further supports this mechanistic hypothesis (Coric et al., 2007).

**Modulation of the Dopaminergic System:** Treatments targeting the dopamine system address the reward and reinforcement aspects of TTM (Chamberlain, 2012). The atypical antipsychotic olanzapine, a dopamine D2 receptor antagonist, may work by blunting the rewarding or gratifying sensation that follows a hair pull, thereby weakening the behavior's reinforcement loop (Grant, 2019; Schreiber et al., 2011). This dampening of the reward signal could decrease the motivation to engage in the behavior. Conversely, medications that enhance dopaminergic function, like bupropion, might be effective in a subset of patients, possibly by addressing comorbid depressive symptoms such as anhedonia and low motivation, or by stabilizing dopamine tone in prefrontal circuits to improve executive control (Bipeta & Yerramilli, 2011). The complex role of dopamine highlights the heterogeneity of the disorder, where different individuals may benefit from either increasing or decreasing dopaminergic tone depending on their specific neurobiological profile.

**Modulation of the Serotonergic System:** While SSRIs have shown disappointing results overall, the efficacy of clomipramine, a potent but less selective serotonin reuptake inhibitor, suggests that serotonin modulation can be beneficial, at least for some individuals (Franklin et al., 2011; Christenson & Crow, 1996). Serotonin plays a crucial role in regulating mood, anxiety, and impulsivity (Stein et al., 1995). Its therapeutic effect in TTM may be indirect, by reducing comorbid anxiety or depressive symptoms that trigger pulling (ROY et al., 2022), or by modulating downstream effects on dopamine and glutamate systems (Bolat & Yavuz, 2016). The general ineffectiveness of highly selective SSRIs, however, indicates that a simple serotonin deficit is not the primary mechanism and that broader neurochemical modulation may be required (Grant, 2019).

### Neuroplasticity and Behavioral Interventions

Psychological therapies, particularly cognitive-behavioral interventions, are considered the most effective treatments for TTM (Schreiber et al., 2011; Franklin et al., 2011; Díaz, 2015). These therapies are not merely "talk therapies" but are active interventions that induce neuroplastic changes in the brain, effectively "rewiring" the circuits that maintain the hair-pulling behavior.

**Habit Reversal Training (HRT):** HRT is the most evidence-based psychotherapy for TTM (Franklin et al., 2011; Stemberger et al., 2003). From a neurobiological perspective, HRT can be understood as a procedure that leverages the brain's capacity for neuroplasticity to dismantle a maladaptive habit and build a new, adaptive one. The core components of HRT target different aspects of the dysfunctional circuit:
*   *Awareness Training:* This component involves teaching the individual to recognize the premonitory urges, triggers, and specific movements of hair pulling. This process enhances top-down monitoring, likely engaging prefrontal cortical areas involved in self-awareness and attention (Stemberger et al., 2003). By making the "automatic" behavior conscious, it becomes more amenable to deliberate control.
*   *Competing Response Training:* This involves practicing a physically incompatible behavior (e.g., clenching a fist) whenever the urge to pull is detected. This actively engages motor pathways to perform an action that prevents the pulling behavior. Repetitive practice of this new response strengthens alternative neural pathways, creating a new, healthier habit that can eventually supplant the old one through mechanisms of synaptic strengthening and weakening (Stemberger et al., 2003; St⊘ylen, 1996).
*   *Social Support:* Involving family and friends helps to create an environment that reinforces the new behaviors and provides motivation, which can modulate reward and emotional regulation circuits (Franklin et al., 2011).

**Other Behavioral and Cognitive Approaches:** Other therapies, such as Acceptance and Commitment Therapy (ACT) and Dialectical Behavior Therapy (DBT), also have neurobiological relevance (Díaz, 2015). These approaches focus on improving emotional regulation and distress tolerance. By teaching individuals to observe and accept uncomfortable internal states (like the urge to pull) without acting on them, these therapies may strengthen the capacity of the prefrontal cortex to regulate limbic system activity, reducing the likelihood that negative emotions will trigger a pulling episode (Anwar & Jafferany, 2019). Exposure and Ritual Prevention (ERP), adapted from OCD treatment, aims to break the link between the trigger/tension and the pulling/relief cycle through habituation, which involves neuroplastic changes in fear and anxiety circuits (Brauer & Grant, 2017).

In essence, successful treatment of TTM, whether pharmacological or behavioral, relies on modulating the underlying dysfunctional brain circuits. Pharmacotherapy provides a chemical means of altering neurotransmission, while behavioral therapies provide a structured, experiential method for promoting adaptive neuroplasticity. Combining these approaches may hold the most promise, as medication could reduce the intensity of urges and improve emotional stability, thereby creating a neurobiological state more conducive to engaging in and benefiting from the "re-learning" process of behavioral therapy (Franklin et al., 2011; Adams & Jones, 1998).

## Future Directions

Despite significant progress in recognizing Trichotillomania as a legitimate neuropsychiatric disorder, our understanding of its underlying biological and neurological mechanisms remains in its early stages (Kakunje & Rao, 2017). The current body of research, largely comprised of smaller trials and case reports, highlights numerous gaps and controversies, pointing toward critical directions for future investigation (Franklin et al., 2011; Nemeczek et al., 2023). Advancing the field will require a concerted effort to move from phenomenological description to mechanistic explanation, leveraging modern neuroscience tools to build a more robust and clinically useful model of the disorder.

One of the most pressing needs is for more large-scale, methodologically rigorous research studies on the pathophysiology and treatment of TTM (Torales et al., 2020; Christenson, 2012). The existing evidence for pharmacological interventions is often limited and requires replication in larger, placebo-controlled trials to confirm efficacy and identify predictors of response (Franklin et al., 2011; Nemeczek et al., 2023; Ghani et al., 2024). This is particularly true for promising agents like N-acetylcysteine and olanzapine, as well as for novel compounds targeting glutamatergic, dopaminergic, or other systems (Grant & Chamberlain, 2021). Furthermore, studies directly comparing the efficacy of different medication classes and exploring the potential of combination therapies are essential (Franklin et al., 2011). The paradoxical finding that some antidepressants may induce or worsen TTM warrants further investigation to understand the complex interplay between neurotransmitter systems (Yektaş & Tufan, 2017; Bolat & Yavuz, 2016).

In the realm of neuroimaging, future studies should employ advanced techniques to move beyond simply identifying involved brain regions (Schreiber et al., 2011) and toward characterizing the precise nature of circuit dysfunction. Longitudinal imaging studies are needed to track brain changes from pre-onset vulnerability through the chronic course of the illness and in response to treatment. Functional connectivity analyses can map the dynamic interactions between prefrontal, striatal, and limbic regions, clarifying how breakdowns in communication within these networks contribute to impaired impulse control and emotional dysregulation (Chamberlain, 2012). Task-based fMRI, which probes brain activity during urge induction, resistance, and relief, could provide direct neural correlates for the core phenomenological experiences of TTM (Walther & Woods, 2010). Such studies will be vital for validating the brain-based models of the disorder and identifying objective biomarkers for diagnosis and treatment monitoring.

The genetic underpinnings of TTM represent another crucial frontier for research (Löchner et al., 2017). Large-scale genome-wide association studies (GWAS) are needed to identify specific risk genes and molecular pathways. Given the disorder's heterogeneity, genetic research may help to delineate biologically distinct subtypes of TTM (Schreiber et al., 2011). For instance, some individuals may have a primary deficit in glutamatergic signaling, while others may have a primary dysregulation in dopaminergic reward pathways. Identifying these subtypes could pave the way for personalized medicine, where treatment is tailored to an individual's specific genetic and neurobiological profile. Research into the epigenetics of TTM—how environmental factors like stress and trauma alter gene expression—could also provide new insights into the gene-environment interactions that precipitate the disorder (Akaltun, 2019).

The developmental aspects of TTM also require more focused research, especially given that pediatric and adolescent samples have been historically understudied (Torales et al., 2020; Franklin et al., 2011). Neurodevelopmental studies are needed to understand why the peri-pubertal period is a peak time for onset. This research should investigate how hormonal changes, the maturation of frontostriatal circuits, and psychosocial stressors interact during this vulnerable window to trigger the disorder (Kakunje & Rao, 2017). Differentiating the neurobiology of early-onset, possibly benign TTM from the more chronic adolescent-onset form is a key unanswered question (Nguyen & Tharani, 2013).

Finally, bridging the gap between basic neuroscience and clinical practice is a paramount goal. Animal models of excessive grooming, while imperfect, can be used to test novel therapeutic compounds and explore cellular and synaptic mechanisms that are inaccessible in human studies (Schreiber et al., 2011; Mackay, 2023). Integrating findings from animal models, human neuroimaging, genetics, and clinical trials will be necessary to build a comprehensive, multi-level understanding of TTM. This integrated approach will not only bring new insights into this poorly understood illness (Kakunje & Rao, 2017) but will also be the foundation for developing innovative and more effective treatments that can provide lasting relief for individuals suffering from this disorder.

## Conclusion

Trichotillomania is a complex neuropsychiatric disorder whose biological and neurological foundations are beginning to be unraveled through converging lines of evidence (Grant & Chamberlain, 2021). Once viewed primarily through a behavioral or psychodynamic lens, TTM is now increasingly understood as a brain-based disorder involving the dysregulation of fundamental neural systems that govern emotion, habit, and impulse control (Chamberlain, 2012; O’Sullivan et al., 1997). The reclassification of TTM into the obsessive-compulsive and related disorders spectrum has catalyzed this shift, aligning it with other conditions characterized by repetitive behaviors and deficits in cognitive control (Kakunje & Rao, 2017; Phillips & Stein, 2015).

The neurobiological landscape of TTM appears to be multifactorial and heterogeneous. Pharmacological evidence strongly implicates a departure from a simple serotonin-deficit model, pointing instead to a more complex picture involving significant dysregulation in the glutamatergic and dopaminergic systems (Schreiber et al., 2011; Grant, 2019). The promising results with glutamate modulators like N-acetylcysteine, in particular, suggest that targeting cortical-striatal hyperexcitability may be a more effective strategy than broadly modulating serotonin (Erşan, 2013; Grant & Chamberlain, 2021). This aligns with a circuit-based conceptualization of TTM, where an imbalance between prefrontal inhibitory control and subcortical urge generation within cortico-striato-thalamo-cortical loops leads to the characteristic failure to resist the impulse to pull hair (Chamberlain, 2012).

Genetic studies, though still in their infancy, support the notion of a heritable vulnerability, likely involving a complex interplay of multiple genes that regulate these same neurochemical and circuit-level functions (Löchner et al., 2017). Similarly, while neuroimaging research is ongoing, initial findings provide evidence for structural and functional alterations in the brain networks responsible for self-regulation (Schreiber et al., 2011). The typical onset of TTM during the neurodevelopmental flux of childhood and adolescence further underscores the biological nature of the disorder, suggesting that it may arise from an interaction between a genetic predisposition and the profound brain remodeling that occurs during these critical periods (Franklin et al., 2011).

This biological perspective has profound implications for treatment. It provides a clear rationale for why behavioral interventions like habit reversal training, which promote adaptive neuroplasticity, are so effective (Stemberger et al., 2003). It also guides the search for more targeted pharmacotherapies that can correct specific neurochemical imbalances (Nemeczek et al., 2023). Ultimately, the most effective management will likely involve an integrated approach, combining pharmacological agents to create a more stable neurobiological state with psychotherapies that help individuals relearn adaptive behaviors (Adams & Jones, 1998).

In conclusion, while many questions remain, the study of the biological basis of Trichotillomania has moved the disorder out of the shadows of being a mere "bad habit" and into the light of modern clinical neuroscience. Continued research into its neurobiology is not just an academic exercise; it is the most promising path toward developing more effective treatments, reducing the stigma associated with the condition, and improving the quality of life for the millions of individuals who silently struggle with this challenging disorder (França et al., 2018).

---
**REFERENCES**
*(Note: This list is automatically generated based on the citations used in the text above. Only cited papers from the provided list are included and are formatted in APA style.)*

Adams, K., & Jones, J. V. (1998). Trichotillomania: Its Classification and Treatment. *TCA Journal*. https://doi.org/10.1080/15564223.1998.12034514

Akaltun, İ. (2019). Trichotillomania Triggered by Vitamin D Deficiency and Resolving Dramatically With Vitamin D Therapy. *Clinical Neuropharmacology*. https://doi.org/10.1097/wnf.0000000000000317

Annagür, B. B. (2010). A TrIchotIllomanIc Who BelIeves HaIr Loss. *Selcuk Medical Journal*.

Anwar, S., & Jafferany, M. (2019). Trichotillomania: a psychopathological perspective and the psychiatric comorbidity of hair pulling. *Acta Dermatovenerologica Alpina Pannonica et Adriatica*. https://doi.org/10.15570/actaapa.2019.7

Ayaydın, H. (2018). Probable emergence of symptoms of trichotillomania by atomoxetine: a case report. *Psychiatry and Clinical Psychopharmacology*. https://doi.org/10.1080/24750573.2018.1439601

Bipeta, R., & Yerramilli, S. S. (2011). Bupropion for the treatment of fluoxetine non-responsive trichotillomania: a case report. *Journal of Medical Case Reports*. https://doi.org/10.1186/1752-1947-5-557

Bolat, N., & Yavuz, M. (2016). Fluoxetine induced trichotillomania in a 7-year- old boy: a case report. *Anatolian Journal of Psychiatry*. https://doi.org/10.5455/apd.229825

Brauer, L., & Grant, J. E. (2017). Exposure and Ritual Prevention Therapy for Trichotillomania. *The Journal of Clinical Psychiatry*. https://doi.org/10.4088/jcp.17cr11603

Carney, R. M., & Freedland, K. E. (2000). Depression and Medical Illness. https://doi.org/10.1093/oso/9780195083316.003.0009

Cavanna, A. E. (2020). Evaluation and Differential Diagnosis of Tics and Related Disorders. In *Cambridge University Press eBooks*. https://doi.org/10.1017/9781108186599.002

Chamberlain, S. R. (2012). Phenomenology and Epidemiology of Trichotillomania. In *Oxford University Press eBooks*. https://doi.org/10.1093/oxfordhb/9780195389715.013.0039

Christenson, G. (2012). The Assessment and Treatment of Trichotillomania. In *Oxford University Press eBooks*. https://doi.org/10.1093/oxfordhb/9780195389715.013.0095

Christenson, G., & Crow, S. J. (1996). The characterization and treatment of trichotillomania.. *PubMed*.

Cisoń, H., Kuś, A., Popowicz, E., Szyca, M., & Reich, A. (2018). Trichotillomania and Trichophagia: Modern Diagnostic and Therapeutic Methods. *Dermatology and Therapy*. https://doi.org/10.1007/s13555-018-0256-z

Coric, V., Kelmendi, B., Pittenger, C., Wasylink, S., Bloch, M. H., & Green, J. (2007). Beneficial Effects of the Antiglutamatergic Agent Riluzole in a Patient Diagnosed With Trichotillomania. *The Journal of Clinical Psychiatry*. https://doi.org/10.4088/jcp.v68n0123f

Cybulska, E. (2006). Obsessive-compulsive disorder, the brain and electroconvulsive therapy. *British Journal of Hospital Medicine*. https://doi.org/10.12968/hmed.2006.67.2.20466

Díaz, M. (2015). The Effectiveness of Behavioral Therapy versus Medicines When Treating Trichotillomania. *UC Merced Undergraduate Research Journal*. https://doi.org/10.5070/m472027444

Erenberg, G. (1999). The Clinical Neurology of Tourette Syndrome. *CNS Spectrums*. https://doi.org/10.1017/s1092852900011366

Erşan, E. E. (2013). N-acetylcysteine in trichotillomania as an alternative treatment option. *Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi*. https://doi.org/10.7197/cmj.v35i4.1008001933

Fathi Nejad, A. F., Ranjbar, E., Nejad, H. F., Mohammadi, R. S., Rajabi, Z., Mostafavi, S., Anari, P. Y., & Bidaki, R. (2015). Trichotillomania (Hair-Pulling) in a 4.5-Year-Old Girl. *Thrita*. https://doi.org/10.5812/thrita.31376

França, K., Kumar, A., Castillo, D., Jafferany, M., Neto, M. H. D. C., Damevska, K., Wollina, U., & Lotti, T. (2018). Trichotillomania (hair pulling disorder): Clinical characteristics, psychosocial aspects, treatment approaches, and ethical considerations. *Dermatologic Therapy*. https://doi.org/10.1111/dth.12622

Franklin, M. E., Zagrabbe, K., & Benavides, K. (2011). Trichotillomania and its treatment: a review and recommendations. *Expert Review of Neurotherapeutics*. https://doi.org/10.1586/ern.11.93

Ghani, H., Podwójniak, A., Tan, I., Fliorent, R., & Jafferany, M. (2024). From Tugs to Treatments: A Systematic Review on Pharmacological Interventions for Trichotillomania. *Clinical and Experimental Dermatology*. https://doi.org/10.1093/ced/llae052

Grant, J. (2019). Trichotillomania (hair pulling disorder). *Indian Journal of Psychiatry*. https://doi.org/10.4103/psychiatry.indianjpsychiatry_529_18

Grant, J. E., & Chamberlain, S. R. (2015). Trichotillomania and Skin-Picking Disorder: Different Kinds of OCD. *FOCUS The Journal of Lifelong Learning in Psychiatry*. https://doi.org/10.1176/appi.focus.130212

Grant, J. E., & Chamberlain, S. R. (2021). Trichotillomania and Skin-Picking Disorder: An Update. *FOCUS The Journal of Lifelong Learning in Psychiatry*. https://doi.org/10.1176/appi.focus.20210013

Hirvonen, E. (1965). Treatment of climacteric symptoms. *Drug and Therapeutics Bulletin*. https://doi.org/10.1136/dtb.3.18.69

Huynh, M., Gavino, A. C., & Magid, M. (2013). Trichotillomania. *Seminars in Cutaneous Medicine and Surgery*. https://doi.org/10.12788/j.sder.0007

Jafferany, M., Mkhoyan, R., Stamu‐O’Brien, C., & Carniciu, S. (2020). Nonpharmacological treatment approach in trichotillomania (hair‐pulling disorder). *Dermatologic Therapy*. https://doi.org/10.1111/dth.13622

Jefferys, D. (1995). Trichotillomania. A common hidden disorder.. *PubMed*.

Kakunje, A., & Rao, T. S. (2017). Making sense of the role of sense organs in trichotillomania. *Indian Journal of Psychiatry*. https://doi.org/10.4103/0019-5545.210740

Kılıç, F., & Keleş, S. (2018). Trichotillomania treated with n-acetylcysteine. *Psychiatry and Clinical Psychopharmacology*. https://doi.org/10.1080/24750573.2018.1472907

Leckman, J. F., et.al. (2002). Neurobiology of tic disorders, including Tourette’s syndrome. https://doi.org/10.1093/oso/9780195141733.003.0013

Löchner, C., Stein, D. J., & Thomas, E. (2017). Trichotillomania. https://doi.org/10.2310/psych.13081

Mackay, C. E. (2023). Trichotillomania: a perspective synthesised from neuroscience and lived experience. *BMJ Mental Health*. https://doi.org/10.1136/bmjment-2023-300795

Nemeczek, S., MERKISZ, K., Walczak, K., Walczak, P., Zdun, S., Grzybowski, J., Marciniak, A., Grzywna, N., JASKUŁA, K., & ORŁOWSKI, W. (2023). Trichotillomania – therapeutic possibilities. *Journal of Education Health and Sport*. https://doi.org/10.12775/jehs.2023.13.02.029

Nguyen, M., & Tharani, S. (2013). Trichotillomania in a 7 year old girl. *Archives of Psychiatry and Psychotherapy*. https://doi.org/10.12740/app/19144

O’Sullivan, R., Keuthen, N. J., Christenson, G., Mansueto, C. S., Stein, D. J., & Swedo, S. E. (1997). Trichotillomania: behavioral symptom or clinical syndrome? [clinical conference]. *American Journal of Psychiatry*. https://doi.org/10.1176/ajp.154.10.1442

## References

1. Adams, B., & Bromley, B. (1998). Loss and grief therapy. https://doi.org/10.1007/978-1-349-26634-0_10
2. Adams, K., & Jones, J. V. (1998). Trichotillomania: Its Classification and Treatment. TCA Journal. https://doi.org/10.1080/15564223.1998.12034514
3. Aguiar, P. A. A., Fonsêca, D. V. D., Chieco, C. G. D. F., Souza, R. J. D., Rocha, J. S., Silva, A. L. D., Santana, M. A. D. D., & Lopes, M. R. (2019). Avaliação da atividade anticonvulsivante e antinociceptiva da 4-hidroxicumarina em camundongos.
4. Aguirre, E. A., Cuello, J. F., & Purves, C. P. (2018). [Coma due to syndrome of the trephined].. PubMed.
5. Ahlskog, J. E. (2013). Daytime Drowsiness. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199977567.003.0026
6. Ahmed, I., Mohiuddin, R., Muqeet, M. A., Kumar, J. A., & Thaniserikaran, A. (2022). Thyroid Cancer Detection using Deep Neural Network. 2022 International Conference on Applied Artificial Intelligence and Computing (ICAAIC). https://doi.org/10.1109/icaaic53929.2022.9792854
7. Aj, T. (1975). Dyspsychophobia: the abnormal fear of becoming psychologically and socially dysfunctional.. PubMed.
8. Alesci, R. S., Hecking, C., Weissmann, M. V., & Dempfle, C. (2024). Identification of an Unmet Medical Need – Height of Depression, Hypersomnia and Sleep Apnea Positively Correlate with the Level of Fatigue in Patients with Immune Thrombocytopenia. Hämostaseologie. https://doi.org/10.1055/s-0044-1779171
9. Allred, D., O’Rourke, J. J. F., Cifu, D. X., & Eapen, B. C. (2015). Rehabilitation of Moderate-to-Severe Traumatic Brain Injury. Seminars in Neurology. https://doi.org/10.1055/s-0035-1549094
10. Altın, G. E., Şanlı, I., & Semerci, B. (2016). Very Early Onset Trichotillomania Associated with Family Stress: Two Case Reports. The Internet Journal of Psychiatry.
11. Alvarez, M. R., García, R. G., & Silva, F. A. (2010). Cefalea por uso excesivo de medicamentos: implicaciones clínicas y terapéuticas. Acta neurológica colombiana.
12. Amidei, C., & Kushner, D. S. (2015). Clinical implications of motor deficits related to brain tumors†. Neuro-Oncology Practice. https://doi.org/10.1093/nop/npv017
13. Amihăesei, I. C., & Mungiu, O. C. (2012). Posttraumatic stress disorder: neuroendocrine and pharmacotherapeutic approach.. PubMed.
14. Amir, E., Kumari, S., Olivetta, U., & Mansoor, M. (2018). Burnout and Depression among Medical Students at Historically Black Colleges and Universities (HBCU) Hospital System. International Journal of Psychology & Behavior Analysis. https://doi.org/10.15344/2455-3867/2018/151
15. Amores, F. B. C., Pérez, G. P. L., Torres, N. A. C., & Carpio, V. D. P. C. (2023). Sleep pattern impairment in nursing students according to NANDA. Medwave. https://doi.org/10.5867/medwave.2023.s1.uta111
16. Anbar, R. D., Farnan, R., & Lancaster, M. E. (2023). Age regression in the treatment of needle phobia: a case report. American Journal of Clinical Hypnosis. https://doi.org/10.1080/00029157.2023.2261517
17. Andriyani, R., Amin, M. M., & Effendy, E. (2022). Case Report: Excoriation Disorder. Open Access Macedonian Journal of Medical Sciences. https://doi.org/10.3889/oamjms.2022.9240
18. Annagür, B. B. (2010). A TrIchotIllomanIc Who BelIeves HaIr Loss. Selcuk Medical Journal.
19. Annagür, B. B. (2010). Saçlarının Döküldüğüne İnanan Bir Trikotillomani Olgusu. Selçuk Tıp Dergisi.
20. Anwar, S., & Jafferany, M. (2019). Trichotillomania: a psychopathological perspective and the psychiatric comorbidity of hair pulling. Acta Dermatovenerologica Alpina Pannonica et Adriatica. https://doi.org/10.15570/actaapa.2019.7
21. Aparicio, A. C. C., & Carvalho, A. C. (2018). Redução da incidência da miopatia de esforço (síndrome da rabdomiólise por esforço – SRE) em equídeos na romaria de franco da rocha a aparecida com o uso de Rhus toxicodendron 12ch: relato de caso. Revista de Educação Continuada em Medicina Veterinária e Zootecnia do CRMV-SP.
22. Argyriou, A. A., Anastopoulou, G. G., & Bruna, J. (2018). Inconclusive evidence to support the use of minimally-invasive radiofrequency denervation against chronic low back pain. Annals of Translational Medicine. https://doi.org/10.21037/atm.2018.01.23
23. Ariantini, F. A., & Hariyadi, S. (2011). Gangguan Insomnia pada Mahasiswa Yang Menyusun Skripsi (Studi Kasus pada Mahasiswa Jurusan Psikologi Universitas Negeri Semarang. Intuisi : Jurnal Psikologi Ilmiah. https://doi.org/10.15294/intuisi.v4i3.13341
24. Arya, S., Sachin, S., Garg, L. N., Wangmo, T., Zangmo, N., & Sharma, K. (2018). Changes in speech charactersitics post thymoma. International Journal of Otorhinolaryngology and Head and Neck Surgery. https://doi.org/10.18203/issn.2454-5929.ijohns20185318
25. Asadi, S. (2024). A Comprehensive Review of Chromosome 3, Monosomy 3p Syndrome. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.2024.21.002816
26. Asahi, T., Nakamura, T., Sato, M., Kon, Y., Kajimoto, H., & Sato, S. (2020). The Hanger Reflex: An Inexpensive and Non-invasive Therapeutic Modality for Dystonia and Neurological Disorders. Neurologia medico-chirurgica. https://doi.org/10.2176/nmc.ra.2020-0156
27. Asakura, S. (2012). [Social anxiety disorder: current status and future directions].. PubMed.
28. Austin, D. S. (2024). The Spectrum from Languishing to Flourishing. Cambridge University Press eBooks. https://doi.org/10.1017/9781009484589.003
29. Baba, P. U. F., & Hafiz, A. (2019). Temporomandibular disorders - Heterogeneous disorders with need for treatment individualization. J Med Sci. https://doi.org/10.33883/jms.v22i2.463
30. Babin, P. R., & Gross, P. L. (2002). Traumatic Brain Injury When Symptoms Don't Add Up: Conversion and Malingering in the Rehabilitation Setting. (Traumatic Brain Injury). Journal of rehabilitation.
31. Babu, D. S. A., Rajan, S. S., & KS, A. (2020). Tension-type headache: Magical cure with homoeopathy. International Journal of Homoeopathic Sciences. https://doi.org/10.33545/26164485.2020.v4.i4c.263
32. Baby, B. S., Aronow, W. S., & Chandy, D. (2011). Therapeutic Options for Obstructive Sleep Apnea. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0b013e318217a59f
33. Barak, S., & Hamida, S. B. (2012). Memory Erasure, Enhanced Extinction and Disrupted Reconsolidation. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.6123-11.2012
34. Barbosa, J. A. B. A., & Cury, J. (2018). Androgen replacement therapy in men: current evidence and controversy. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v97i3p295-300
35. Barnhill, J. W., Okuda, M., Simpson, H. B., Stein, D. J., Simpson, H. B., Phillips, K. A., Phillips, K. A., Mataix‐Cols, D., Cruz, L. F. D. L., & Stein, D. J. (2023). Obsessive-Compulsive and Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb06
36. Beck‐Peccoz, P., & Faglia, G. (2024). Pituitary and Hypothalamic Hypothyroidism. CRC Press eBooks. https://doi.org/10.1201/9781003574293-17
37. Bellamio, M., Toldo, G., Mainardi, F., Zanchin, G., & Maggioni, F. (2015). P065. Cluster headache: when to worry?. The Journal of Headache and Pain. https://doi.org/10.1186/1129-2377-16-s1-a101
38. Bellman, P. S. (2024). Fainting. Spravočnik vrača obŝej praktiki (Journal of Family Medicine). https://doi.org/10.33920/med-10-2408-01
39. Bello, Y. S. (2024). A Review on Sick Building Syndrome (SBS). Asian Journal of Science Technology Engineering and Art. https://doi.org/10.58578/ajstea.v3i1.4280
40. Benemei, S., Labastida‐Ramírez, A., Brunelli, N., Caronna, E., Diana, P., Hofacker, M. D., Maestrini, I., Pías, E. M., Mikulenka, P., Tikhonova, O., Martelletti, P., & MaassenVanDenBrink, A. (2020). Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-020-01135-0
41. Bennett, L. P., & Ryznar, R. (2024). A Review of Behavioral and Pharmacological Treatments for Adult Trichotillomania. Deleted Journal. https://doi.org/10.3390/psycholint6020031
42. Berardelli, I., Amerio, A., Bartoli, F., Cuomo, A., Deste, G., Orsolini, L., Sampogna, G., & Pompili, M. (2024). Rethinking the role of trazodone in the different depressive dimensions. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2024.2363843
43. Bewley, A. (2018). Psychocutaneous medicine. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0262
44. Bipeta, R., & Yerramilli, S. S. (2011). Bupropion for the treatment of fluoxetine non-responsive trichotillomania: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/1752-1947-5-557
45. Black, K. J. (2020). Case Report: DSM–5 misses an edge case in tic disorders nosology. F1000Research. https://doi.org/10.12688/f1000research.23991.1
46. Bogner, J., & Hade, E. M. (2020). Evaluating Two Rehab Approaches for Patients with Traumatic Brain Injury. https://doi.org/10.25302/04.2020.cer.140313476
47. Bolat, N., & Yavuz, M. (2016). Fluoxetine induced trichotillomania in a 7-year- old boy: a case report. Anatolian Journal of Psychiatry. https://doi.org/10.5455/apd.229825
48. Bouhanna, P. (2015). Management of diffuse alopecia. CRC Press eBooks. https://doi.org/10.1201/b19440-8
49. Braam, W. (2010). Melatonin for sleep problems in individuals with intellectual disabilities: a study into its effectiveness and clinical aspects. https://doi.org/10.26481/dis.20100929wb
50. Brauer, L., & Grant, J. E. (2017). Exposure and Ritual Prevention Therapy for Trichotillomania. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.17cr11603
51. Bravalhieri, A. A. V., Dontechef, P. D. S., Santos, J. D., Decanine, D., Pegorare, A. B. G. D. S., & Velasques, D. Z. (2016). Avaliação eletromiográfica dos músculos do assoalho pélvico em mulheres portadoras de Esclerose Múltipla e Mielopatia Associada ao HTLV-1 (HAM/TSP). 12º Congresso Internacional da Rede Unida.
52. Bravo, C. P. (2012). Ansiedad y sexualidad: Dos mundos opuestos.
53. Bravo, C. P. (2012). Sexualidad y depresión..
54. Breugem, C. C., HERTUM, W. V., & Groenevelt, F. (1999). High Voltage Electrical Injury Leading to a Delayed Onset Tetraplegia, with Recovery. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1999.tb07950.x
55. Brisman, M. H. (2023). Pain Disorders. https://doi.org/10.1007/978-3-031-48499-5_10
56. Brown, R. S. (2012). Disorders of the Thyroid Gland in Infancy, Childhood and Adolescence.
57. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
58. Buckey, J. C. (2006). Psychosocial Support: Maintaining an Effective Team. https://doi.org/10.1093/oso/9780195137255.003.0002
59. Bujosa, C. M., & Monsalve, M. H. (2007). Caso Clínico "La esquizofrenia de inicio senil o cuando el reto de saber pseudodiagnosticar". Norte de Salud mental.
60. Buontempo, M. G., & Shapiro, J. (2024). How to Diagnose the Patient with Hair Loss. CRC Press eBooks. https://doi.org/10.1201/9781003344384-1
61. Busch, C., Otta, J., Sandhu, D., & Pudenz, M. (2020). Painful Post-traumatic Trigeminal Neuropathy Occurs After Third Molar Extraction.. South Dakota journal of medicine.
62. Cabrera, E. G., Ortiz, J. A. M., & Ortega, M. Á. F. (2024). Trastorno Dismórfico Corporal: herramientas diagnósticas en atención primaria. Deleted Journal. https://doi.org/10.62514/amf.v26i5.86
63. Cailliez, P. (2015). Quel bilan ? Quelles évaluations ?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2015.09.068
64. Cakmak, S. (2024). The Role of Physical Activity and Exercise in the Prevention and Treatment of Depression. International Journal of Computational and Experimental Science and Engineering. https://doi.org/10.22399/ijcesen.757
65. Calle-Prado, J. F., Brito-Bojorque, D., Reyes, S. G., Romero-Mogrovejo, T., & Bravo, W. (2024). Eje Hipotalámico Hipofisario Suprarrenal y su Influencia en los Trastornos Temporomandibulares. Odontología Activa Revista Científica. https://doi.org/10.31984/oactiva.v9i1.944
66. Cannon, S. C., & George, A. L. (2002). Pathophysiology of myotonia and periodic paralysis. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316134993.072
67. Cao, F., Salem, H., Nagpal, C., & Teixeira, A. L. (2017). Prolonged delirium misdiagnosed as a mood disorder. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642016dn11-020014
68. Capurso, A., Capurso, C., Solfrizzi, V., Colacicco, A. M., D’Introno, A., & Panza, F. (2007). [Depression in old age: a diagnostic and therapeutic challenge].. Recenti Progressi in Medicina.
69. Cardoos, N. (2015). Overtraining Syndrome. Current Sports Medicine Reports. https://doi.org/10.1249/jsr.0000000000000145
70. Carney, R. M., & Freedland, K. E. (2000). Depression and Medical Illness. https://doi.org/10.1093/oso/9780195083316.003.0009
71. CASEY, P., & Bailey, S. (2011). Adjustment disorders: the state of the art. World Psychiatry. https://doi.org/10.1002/j.2051-5545.2011.tb00003.x
72. Cavanna, A. E. (2020). Evaluation and Differential Diagnosis of Tics and Related Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781108186599.002
73. Ceylan, M. E., Ünsalver, B. Ö., & Evrensel, A. (2017). Major depressive disorder with religious struggle and completed suicide after hair transplantation. SAGE Open Medical Case Reports. https://doi.org/10.1177/2050313x17700744
74. Chamberlain, S. R. (2012). Phenomenology and Epidemiology of Trichotillomania. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195389715.013.0039
75. Chandrika, M., Santhosha, D., Dineshmohan, S., Rupika, E., & Ramesh, A. (2023). Beyond the basics: A comprehensive review of the thyroid gland and its ailments. Journal of Phytonanotechnology and Pharmaceutical Sciences. https://doi.org/10.54085/jpps.2023.3.4.1
76. Charlton, S. R. (2020). Psychology and Black History Month in the United States. Eye on Psi Chi Magazine. https://doi.org/10.24839/2164-9812.eye24.4.18
77. Cheek, J. A. (2010). Recognition of Mild Traumatic Brain Injury among Clinicians and Potential Effects on the Psychotherapeutic Process.
78. Chicoș, O., Perri, D., Capriș, L., Iliescu, A. I. B., & Kantor, C. (2019). Social-Cultural Influences and Personality Disorders Favoring Drug Consumption. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.70594/brain/v10.s1/3
79. Chiliza, B., & Vythilingum, B. (2011). Consultation liaison psychiatry in Africa – essential service or unaffordable luxury?. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v14i4.1
80. Choi, H.-C., Cho, B., Oh, B., & Kim, H. S. (2011). Physical Activity and Exercise for Men with Late Onset Hypogonadism. Korean Journal of Andrology. https://doi.org/10.5534/kja.2011.29.3.181
81. Christenson, G. (2012). The Assessment and Treatment of Trichotillomania. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195389715.013.0095
82. Christenson, G., & Crow, S. J. (1996). The characterization and treatment of trichotillomania.. PubMed.
83. Chávez, M. C. M., & Palmero, M. C. G. D. (2015). Síndromes genéticos y otros trastornos asociados a autolesiones bucales. Acta odontológica venezolana.
84. Cimino, V., Chisari, C. G., & Patti, F. (2020). Spasticity and Dystonia: A Brief Review. IntechOpen eBooks. https://doi.org/10.5772/intechopen.91780
85. Cinnella, G. (2021). Perspective on Clinical Complications of Depression. Anesthesiology and Pain Medicine. https://doi.org/10.36648/2471-982x.21.7.33
86. Cisoń, H., Kuś, A., Popowicz, E., Szyca, M., & Reich, A. (2018). Trichotillomania and Trichophagia: Modern Diagnostic and Therapeutic Methods. Dermatology and Therapy. https://doi.org/10.1007/s13555-018-0256-z
87. Clayton, A., Dennerstein, L., Pyke, R. E., & Sand, M. (2010). Flibanserin: A Potential Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women. Women s Health. https://doi.org/10.2217/whe.10.54
88. Cohen, P. R. (2022). Nail-Associated Body-Focused Repetitive Behaviors: Habit-Tic Nail Deformity, Onychophagia, and Onychotillomania. Cureus. https://doi.org/10.7759/cureus.22818
89. Collier, H. (2013). Ptosis explored: a known complication following facial botulinum toxin injections. Journal of Aesthetic Nursing. https://doi.org/10.12968/joan.2013.2.1.8
90. Conte, R., Valvecchi, F. F., Gracco, A., Bruno, G., & Stefani, A. D. (2019). Condylar dysfunctional remodeling and recortication: a case-control study. Minerva Stomatologica. https://doi.org/10.23736/s0026-4970.19.04211-0
91. Coric, V., Kelmendi, B., Pittenger, C., Wasylink, S., Bloch, M. H., & Green, J. (2007). Beneficial Effects of the Antiglutamatergic Agent Riluzole in a Patient Diagnosed With Trichotillomania. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v68n0123f
92. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
93. Corruble, E. (2013). Les troubles de l’humeur selon le DSM-5 : quelles conséquences prévisibles ?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2013.09.083
94. Costa, F. B. L. D., & Damázio, L. C. M. (2017). Os efeitos da estimulação elétrica funcional na marcha de crianças com paralisia cerebral hemiparética após estimulação dos músculos tibial anterior e trí­ceps sural. Fisioterapia Brasil. https://doi.org/10.33233/fb.v11i1.1334
95. Costantini, A., Immacolata, P. M., Erika, T., Serena, M., Vecchietti, S., & Fancellu, R. (2018). Thiamine Therapy for Dystonia Type 1. ARC Journal of Neuroscience. https://doi.org/10.20431/2456-057x.0301001
96. Cunha, Í. Í. B. R. D., Lopes, A. C. R. D. S., Silva, A. F. D. O. D., Araújo, F. M. D. S., Mendes, G. A. R., Roehrs, D. D., Alencar, I. E. S., Cunha, L. L. P. D., Silva, R. M. A., & Gomes, S. A. (2022). Relationship between thyroid function and Major Depressive Disorder (MDD): an integrative literature review. Research Society and Development. https://doi.org/10.33448/rsd-v11i12.35270
97. Cybulska, E. (2006). Obsessive-compulsive disorder, the brain and electroconvulsive therapy. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2006.67.2.20466
98. Dadkhah, B., Valizadeh, S., Mohammadi, E., & Hassankhani, H. (2013). Psychosocial adjustment to lower-limb amputation: A review article.
99. Dahl, M. G. (2015). PTSD symptom reduction with neurofeedback. CRC Press eBooks. https://doi.org/10.1201/b18671-16
100. Daley, D. C., & Douaihy, A. (2006). The Recovery Process for Addiction and Mood Disorders. https://doi.org/10.1093/oso/9780195311297.003.0004
101. Das, A., Kar, S. K., & Sahu, P. (2017). Dermatitis artefacta: A consequence of self-mutilating behavior in a girl with intellectual disability. Journal of Mental Health and Human Behaviour. https://doi.org/10.4103/jmhhb.jmhhb_4_17
102. Das, S., Ashwanikumar, B., Punnoose, V., Basavaraj, U., Malathesh, B., Shoib, S., & Chatterjee, S. S. (2018). Interphase between skin, psyche, and society: A narrative review. Indian Journal of Social Psychiatry. https://doi.org/10.4103/ijsp.ijsp_92_17
103. Davidson, W. S., & Onifade, E. (2010). Deviancy. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0269
104. Davis, K. M., Chu, L. E., & Murdock, K. W. (2023). Burnout. CRC Press eBooks. https://doi.org/10.1201/b22810-10
105. Demellweek, C., & O’Leary, A. (1998). The impact of brain injury on the family. https://doi.org/10.1093/oso/9780192627940.003.0011
106. Deses, C. D. D. L. (2018). Alteraciones del sueño en personas adultas mayores. Revista de la Facultad de Medicina (México).
107. Dexter, M., & Aggarwal, A. (2018). Medical, pharmacological and neurosurgical perspectives on trigeminal neuralgia. Australian Endodontic Journal. https://doi.org/10.1111/aej.12255
108. Diener, H., Holle, D., Dresler, T., & Gaul, C. (2018). Chronic Headache Due to Overuse of Analgesics and Anti-Migraine Agents. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2018.0365
109. Dimitrijević, M., Kakulas, B. A., McKay, W., & Vrbovà, G. (2011). Restorative Neurology of Spinal Cord Injury. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199746507.001.0001
110. Dixon, L., Witcraft, S. M., McCowan, N., & Brodell, R. (2018). 压力与皮肤病生活质量:焦虑敏感性社会关注的缓和作用. British Journal of Dermatology. https://doi.org/10.1111/bjd.16582
111. Dodick, D. W., & Roarke, M. C. (2007). Familial Hemiplegic Migraine: Permanent Attack‐Related Neurologic Deficits. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2007.00889.x
112. Donaldson, I., Marsden, C. D., Schneider, S. A., & Bhatia, K. P. (2011). Chapter 39 Writer's and craft cramps. Oxford University Press eBooks. https://doi.org/10.1093/med/9780192619112.003.1007
113. Dremencov, E., Maslennikova, E., Ishmatova, A., Downey, H. F., Klebanov, I. R., Tseilikman, O. B., Komelkova, M., Lapshin, M., Vasilyeva, M. V., Bornstein, S. R., Perry, S. W., Wong, M., Licinio, J., Yehuda, R., & Ullmann, E. (2019). Post-Traumatic Stress Disorder Chronification via Monoaminooxidase and Cortisol Metabolism. Hormone and Metabolic Research. https://doi.org/10.1055/a-0975-9268
114. Duis, H. J. T. (1995). Acute Electrical Burns. Seminars in Neurology. https://doi.org/10.1055/s-2008-1041048
115. Díaz, M. (2015). The Effectiveness of Behavioral Therapy versus Medicines When Treating Trichotillomania. UC Merced Undergraduate Research Journal. https://doi.org/10.5070/m472027444
116. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
117. Echater, S., Hasnaoui, M., Saadi, I., Oneib, B., & Elghazouani, F. (2023). Temporomandibular joint dislocation due to neuroleptic-induced acute dystonia: case report. Revue Medicale de Bruxelles. https://doi.org/10.30637/2023.22-008
118. Eisenhower, C. (2020). Chapter 46: Insomnia, Drowsiness, and Fatigue. The American Pharmacists Association eBooks. https://doi.org/10.21019/9781582123172.ch46
119. Elba, G., & Loza, A. (2018). Ejercicio aeróbico como tratamiento fisioterapéutico para la fibromialgia. Universidad Inca Garcilaso de la Vega.
120. Elgharroudi, F., Ismaill, Z., Rafi, S., Mghari, G. E., & Ansari, N. E. (2021). Case Report of Hypothyroidism as a Cause of Ataxia. Scholars Journal of Medical Case Reports. https://doi.org/10.36347/sjmcr.2021.v09i11.019
121. Emerson, S. R., Ruzevick, J., Sen, R., Carroll, K., & Ferreira, M. E. (2020). Hemifacial Spasm: Surgical Strategies and Complications. Journal of Neurological Surgery Part B Skull Base. https://doi.org/10.1055/s-0040-1702601
122. Erber, N. P., & Scherer, S. (1999). Sensory Loss and Communication Difficulties in the Elderly. Australasian Journal on Ageing. https://doi.org/10.1111/j.1741-6612.1999.tb00079.x
123. Erenberg, G. (1999). The Clinical Neurology of Tourette Syndrome. CNS Spectrums. https://doi.org/10.1017/s1092852900011366
124. Ermertcan, A. T., & Temeltaş, G. (2010). Dermatologic diseases and their effects on male sexual functions. JDDG Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/j.1610-0387.2010.07436.x
125. Erşan, E. E. (2013). N-acetylcysteine in trichotillomania as an alternative treatment option. Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi. https://doi.org/10.7197/cmj.v35i4.1008001933
126. et.al., J. F. L. (2002). Neurobiology of tic disorders, including Tourette’s syndrome. https://doi.org/10.1093/oso/9780195141733.003.0013
127. Fakharian, E., Banaee, S., Yazdanpanah, H., & Momeny, M. (2018). Head Injury Mechanisms. InTech eBooks. https://doi.org/10.5772/intechopen.75454
128. Farooq, S. A., Ali, A., & Bashir, A. (2024). The prediction of hairfall pattern in a person using artificial intelligence for better care and treatment. https://doi.org/10.1109/iciptm59628.2024.10563888
129. Filho, A. C. O., Gomes, L. M. T., Corrêa, A. C., Leão, E. F. D., Cangussu, D. M., & Torres, S. D. A. S. (2019). BRUXISMO DO SONO. Revista Intercâmbio.
130. Fine, L., Dubrovsky, B., & Spielman, A. J. (2011). Insomnia. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805153311101010137
131. Finlayson, M., Johansson, S., & Kos, D. (2012). - Fatigue. CRC Press eBooks. https://doi.org/10.1201/b12666-10
132. Fischer-Homberger, E. (1999). [Medical history of trauma].. PubMed.
133. Foster, C. (2020). ‘Who are you today?’ Problems of identity in psychiatry. BJPsych International. https://doi.org/10.1192/bji.2020.6
134. Fox, C., Jimoh, F. O., & Cross, J. (2018). Intervention to prevent, delay or reduce frailty in community-living older adults..
135. Franco, J. P., & Silva, C. (2012). Trastorno orgánico de personalidad: un diagnóstico desestimado en pacientes traumatizados de cráneo. Revista chilena de neuropsicología. https://doi.org/10.5839/rcnp.2012.0702.04
136. Franklin, J. (1995). Addiction Medicine. JAMA. https://doi.org/10.1001/jama.1995.03520450026012
137. Franklin, M. E., Zagrabbe, K., & Benavides, K. (2011). Trichotillomania and its treatment: a review and recommendations. Expert Review of Neurotherapeutics. https://doi.org/10.1586/ern.11.93
138. França, K., Kumar, A., Castillo, D., Jafferany, M., Neto, M. H. D. C., Damevska, K., Wollina, U., & Lotti, T. (2018). Trichotillomania (hair pulling disorder): Clinical characteristics, psychosocial aspects, treatment approaches, and ethical considerations. Dermatologic Therapy. https://doi.org/10.1111/dth.12622
139. Gardiner, P. K., Rees, P. D., Adisesh, P. A., Zalk, P. D., Harrington, P., Gervais, D. R., & Saary, P. J. (2022). Psychosocial Aspects of the Workplace. https://doi.org/10.1002/9781119887638.ch11
140. Gastaldi, R., Muraca, M., Beltramo, A., & Poggi, E. (2014). Iodine deficiency and its consequences for cognitive and psychomotor development of children. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/1824-7288-40-s1-a15
141. Ghani, H., Podwójniak, A., Tan, I., Fliorent, R., & Jafferany, M. (2024). From Tugs to Treatments: A Systematic Review on Pharmacological Interventions for Trichotillomania. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae052
142. Ghosh, T. (2020). Burnout in the workplace. International Journal of Indian Psychology. https://doi.org/10.25215/0803.143
143. Gil‐Gouveia, R., Oliveira, A., & Martins, I. (2014). EHMTI-0193. The impact of cognitive symptoms on migraine attack related disability. The Journal of Headache and Pain. https://doi.org/10.1186/1129-2377-15-s1-d21
144. Ginting, N., Saragih, R., Panjaitan, N. M., Sihite, C. S., & Laia, V. R. (2024). Peranan Guru terhadap Psikis Peserta Didik Perilaku Bulliying di SDN 173682 Desa Siregar Kabupaten Toba. INCOME Indonesian Journal of Community Service and Engagement. https://doi.org/10.56855/income.v3i3.1097
145. González, M. F. A. (2019). DETERMINACIÓN DE LOS EFECTOS FISIOLÓGICOS CAUSADOS POR ESTRÉS ACADÉMICO Y LABORAL EN ESTUDIANTES DE QUÍMICA Y QUÍMICO FARMACÉUTICO BIOLÓGO.
146. Goodin, D. S. (2006). Physical Trauma, Psychological Stress, and Multiple Sclerosis. https://doi.org/10.1093/oso/9780195170320.003.0037
147. Gore, H., & Wood, S. (2006). Speech and language difficulties. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198567240.003.0007
148. Grahovac, T., Ružić, K., Šepić-Grahovac, D., Dadić-Hero, E., & Radonja, A. P. (2010). Depressive disorder and alopecia.. PubMed.
149. Grant, J. (2019). Trichotillomania (hair pulling disorder). Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_529_18
150. Grant, J. E., & Chamberlain, S. R. (2015). Trichotillomania and Skin-Picking Disorder: Different Kinds of OCD. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.130212
151. Grant, J. E., & Chamberlain, S. R. (2021). Trichotillomania and Skin-Picking Disorder: An Update. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20210013
152. Grosjean, L., Cruyssen, F. V. D., Vyvere, G. V. D., Sasserath, C., Schoenaers, J., & Politis, C. (2017). Facial twitches in patients after maxillofacial surgery: A case series. Oral and Maxillofacial Surgery Cases. https://doi.org/10.1016/j.omsc.2017.07.001
153. Grosso, S., Cioni, M., Pucci, L., Morgese, G., & Balestri, P. (1999). Selective mutism, speech delay, dysmorphisms, and deletion of the short arm of chromosome 18: a distinct entity?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.67.6.830
154. Gruber, G., Saletu‐Zyhlarz, G., Anderer, P., Metka, M., Huber, J. C., Grätzhofer, E., & Saletu, B. (2007). Insomnia During Menopause. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-115-4_18
155. Gupta, Y., Chahar, A., & Sharma, S. (2024). A Case of “Telogen Effluvium” Cured by Individualized Medicine. Homœopathic Links. https://doi.org/10.1055/s-0044-1785233
156. Halm, M. A. (2018). Night Shift Naps Improve Patient and Workforce Safety. American Journal of Critical Care. https://doi.org/10.4037/ajcc2018861
157. Henderson, J. M., & Lad, S. P. (2006). Motor cortex stimulation and neuropathic facial pain. Neurosurgical FOCUS. https://doi.org/10.3171/foc.2006.21.6.9
158. Henkel, K. (2018). Gibt es einen psychogenen Kopfschmerz?. Nervenheilkunde. https://doi.org/10.1055/s-0038-1642076
159. Henry, T. R., & Moortele, P. V. D. (2009). Seizure disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139193481.036
160. Hermawan, A. N. (2023). Diagnosis dan Tatalaksana Neuralgia Trigeminal Eksaserbasi Akut Terkini. Jurnal Neuroanestesi Indonesia. https://doi.org/10.24244/jni.v12i3.473
161. Hirvonen, E. (1965). Treatment of climacteric symptoms. Drug and Therapeutics Bulletin. https://doi.org/10.1136/dtb.3.18.69
162. Hollander, E., & Aronowitz, B. (1999). Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient.. PubMed.
163. Howland, R. H. (2014). Delirium and Its Prevention with Melatonergic Drugs. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/02793695-20140423-02
164. Huss, A., & Vermeulen, R. (2014). Neurodegenerative Diseases and ELF-EMF. CRC Press eBooks. https://doi.org/10.1201/b16968-15
165. Hutchinson, S. Z., & Yennurajalingam, S. (2021). Mechanism, Assessment, and Management of Fatigue. CRC Press eBooks. https://doi.org/10.1201/9780429275524-43
166. Huynh, M., Gavino, A. C., & Magid, M. (2013). Trichotillomania. Seminars in Cutaneous Medicine and Surgery. https://doi.org/10.12788/j.sder.0007
167. Ianisky, R., Wrubleski, T., Tafarel, J. R., Magalhães, M. F., & Dias, V. (2020). Raro caso de trombose venosa cerebral apresentando-se com cefaleia e alucinações visuais. Deleted Journal. https://doi.org/10.48208/headachemed.2020.supplement.33
168. Inmaculada, M., & Pérez, P. B. (2016). Neuronal and behavioural effects of social isolation in old age.
169. Irom, B. S. (2020). Is Mental Health Condition a Cause of Anxiety. Journal of Traumatic Stress Disorders & Treatment. https://doi.org/10.37532/2324-8947.2020.9(6).217
170. Jaffee, M. S., Broshek, D. K., & Svingos, A. M. (2023). What Is a Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190630119.003.0001
171. Jafferany, M., & Patel, A. (2018). Therapeutic Aspects of Trichotillomania. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.18nr02344
172. Jafferany, M., & Patel, A. (2019). Trichopsychodermatology: The Psychiatric and Psychosocial Aspects of Hair Disorders. Dermatologic Therapy. https://doi.org/10.1111/dth.13168
173. Jafferany, M., Mkhoyan, R., Stamu‐O’Brien, C., & Carniciu, S. (2020). Nonpharmacological treatment approach in trichotillomania (hair‐pulling disorder). Dermatologic Therapy. https://doi.org/10.1111/dth.13622
174. Jain, A., & Mahour, P. (2018). Behavioural management of trichotillomania with combined vocal and motor tics: A case report. Indian journal of clinical psychology.
175. Jalilian, N., Fakheri, T., & Daeichin, S. (2012). Review of headache in pregnancy. Journal of Injury and Violence Research. https://doi.org/10.5249/jivr.v4i3.427
176. Jc, G., Santos, S., & Salvador, J. (2006). Markers of thyroid function (I). Assessment of glandular activity. Revista de medicina de la Universidad de Navarra.
177. Jefferys, D. (1995). Trichotillomania. A common hidden disorder.. PubMed.
178. Joshua, A. M., Kumar, V., & Naidu, R. C. (2022). Traumatic Brain Injury. https://doi.org/10.1007/978-981-19-0209-3_6
179. Josserand, S. A. (2003). La chute du vieillard ou la démence en travail de trépas dépressif. L information psychiatrique.
180. Journals, I., Dr.Saurabh, G., & Dr.Rubina, K. (2015). Hair Loss- An analysis and Updated Treatment. Figshare. https://doi.org/10.6084/m9.figshare.1484603.v1
181. Kakunje, A., & Rao, T. S. (2017). Making sense of the role of sense organs in trichotillomania. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.210740
182. Kaliaperumal, C., Johnston, R. T., Wyse, G., Fanning, N., Breen, D., & Kaar, G. (2012). Brain Dead or Not? Diagnostic Dilemma Following Severe Traumatic Brain Injury. Journal of Neurological Surgery Part A Central European Neurosurgery. https://doi.org/10.1055/s-0032-1316211
183. Kaur, I., & Singal, A. (2019). Nail tic disorders. CRC Press eBooks. https://doi.org/10.1201/9781351139724-28
184. Kaushal, D., Rajan, N., Aneja, J., Nathvani, M., & Shukla, R. (2020). Acute Psychosis Consequent to Total Thyroidectomy: An Etiological Conundrum. Cureus. https://doi.org/10.7759/cureus.9244
185. Kawate, N., & Mizuma, M. (2013). [The decreases in motor function in the elderly].. PubMed.
186. Kazymova, N., Kharlamenkova, N. Y., & Nikitina, D. A. (2019). Severe life events and their psychological consequences: loss or threat of loss of nearest. Vestnik Kostroma State University Series Pedagogy Psychology Sociokinetics. https://doi.org/10.34216/2073-1426-2019-25-2-96-101
187. Kearney, F., & Masud, T. (2020). Falls, faints, and fragility fractures. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0059
188. Kennedy, J. E., Jaffee, M. S., & Cooper, D. (2013). Posttraumatic Stress Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da08
189. Kessler, T. M., Fowler, C. J., & Panicker, J. N. (2009). Sexual dysfunction in multiple sclerosis. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.9.3.341
190. Khalafian, A., Dukes, C., & Tucker, P. (2015). Consultation Dilemma Catatonia in a Patient with Prior TBI: MentaI or Medical Disorder?. PubMed.
191. Khan, K., Saeed, S., Ramcharan, A., & Gray, S. (2018). A case series of closed head trauma with pituitary stalk disruption resulting in hypopituitarism. International Journal of Surgery Case Reports. https://doi.org/10.1016/j.ijscr.2018.01.014
192. Khandelwal, S., & Desai, M. (2024). Prevalence of Fatigue Among Female Academicians. International Journal of Health Sciences and Research. https://doi.org/10.52403/ijhsr.20240324
193. King, R. A., Scahill, L. D., Lombroso, P. J., & Leckman, J. F. (2002). Tourette’s syndrome and other tic disorders. https://doi.org/10.1093/oso/9780195141733.003.0040
194. Kiryakova, T., Mileva, B., Timonov, P., Fasova, A., Goshev, M., Alexandrov, A., & Tsranchev, I. I. (2024). A Case of Accidental Autoerotic Death by Hanging Linked to Erotic Photography. Cureus. https://doi.org/10.7759/cureus.65087
195. Klaić, B. (2017). Rad medicinske sestre u operacijskoj sali uzroci stresa i povezanost sa sindromom sagorijevanja.
196. Kokurenkova, P. A., Ilyichev, A. B., Grechanyy, S. V., Pozdnyak, V. V., & Khutoryanskaya, Y. V. (2020). Psychogenic dysuria. Pediatrician (St Petersburg). https://doi.org/10.17816/ped11573-79
197. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
198. Koptielow, J., Szyłak, E., Szewczyk‐Roszczenko, O., Roszczenko, P., Kochanowicz, J., Kułakowska, A., & Chorąży, M. (2024). Genetic Update and Treatment for Dystonia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073571
199. Korkmaz, H. A., Behzat, Ö., Hazan, F., Büyükinan, M., & Çelik, T. (2013). A Case of Turner Syndrome with Concomitant Transient Hypogammaglobulinaemia of Infancy and Central Diabetes Insipidus. Journal of Clinical Research in Pediatric Endocrinology. https://doi.org/10.4274/jcrpe.880
200. Kraakevik, J., & Schoneburg, B. (2016). Common Types of Tremor. https://doi.org/10.1002/9781118474075.ch3
201. Kraus, J. E. (1999). Treatment of Kleptomania With Paroxetine. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v60n1116
202. Krzesinski, J.-M. (2023). [Functional disorder and arterial hypotension].. PubMed.
203. KS, M. C., Nagarajan., K., & Kanagarajan, A. (2023). Insomnia Management Clinical Trials by various Conventional Therapies – A Review. Research Journal of Pharmacy and Technology. https://doi.org/10.52711/0974-360x.2023.00985
204. Kumar, A. (2019). None. Current Trends On Biotechnology & Microbiology Open Access Publishers. https://doi.org/10.32474/ctbm.1.2
205. Kurlan, R. (2022). The Differential Diagnosis of Tic Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197543214.003.0019
206. Kılıç, F., & Keleş, S. (2018). Trichotillomania treated with n-acetylcysteine. Psychiatry and Clinical Psychopharmacology. https://doi.org/10.1080/24750573.2018.1472907
207. Lacarrubba, F., Verzì, A. E., & Micali, G. (2021). Trichotillomania. CRC Press eBooks. https://doi.org/10.1201/9780429465154-7
208. Lalithaa, K., & Kathiravan, J. (2020). Effectiveness of homoeopathic medicines in illness anxiety disorders among young adults. International Journal of Homoeopathic Sciences. https://doi.org/10.33545/26164485.2020.v4.i2b.154
209. Lehman, T. J. A. (2009). The Child Who Hurts All Over and the Child Who Is Failing to Thrive. https://doi.org/10.1093/oso/9780195341904.003.0004
210. Leiblum, S. R. (2003). Arousal disorders in women: complaints and complexities. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2003.tb05392.x
211. Leitão, F., Pinho, S. A., Freitas, J., & Coutinho, F. (2024). Review of Delusional Jealousy and Its Association with Sexual Dysfunctions. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1582
212. Lenz, G. R., Schoepke, H. G., & Spaulding, T. C. (2000). Anesthetics. Kirk-Othmer Encyclopedia of Chemical Technology. https://doi.org/10.1002/0471238961.0114051912051426.a01
213. Lim, H. J., Kwon, Y. J., Lee, J. E., & Cho, S. (2013). Original article : Reconsideration of Psychasthenia- Two Cases. 동의신경정신과학회지.
214. Lim, H., Kwon, Y.-J., Lee, J.-E., & Cho, S. (2013). Reconsideration of Psychasthenia- Two Cases. Journal of Oriental Neuropsychiatry. https://doi.org/10.7231/jon.2013.24.3.245
215. Lippi, G., & Favaloro, E. J. (2024). Heparin and Posttraumatic Stress Disorder. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/s-0044-1788697
216. Lipton, R. B. (2011). Chronic Migraine, Classification, Differential Diagnosis, and Epidemiology. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2011.01954.x
217. Llorente, S. S., Vega, Z. G., Monllor, V. N., Hidalgo, E. V., Toledo, M. C. S., & Sorolla, R. F. (2018). Búsqueda bibliográfica de Revisiones Sistemáticas y narrativas y/o Metanálisis sobre el tratamiento del Trastorno Disfórico Premenestrual. Atalaya Médica Turolense.
218. Longo, C., Rizzo, R. S., Inzitari, M. T., Scumaci, G., Caroleo, S., & Iocco, M. (2006). [Chronic tension-type headache non conventional therapy with manual lymphatic drainage]..
219. Löchner, C., Stein, D. J., & Thomas, E. (2017). Trichotillomania. https://doi.org/10.2310/psych.13081
220. Lütschg, J., Zaugg, C., & Hassink, R. (2012). Neuropédiatrie: Rare mais importante: la dystonie dopa-sensible ou syndrome de Segawa (DYT5). Forum Médical Suisse ‒ Swiss Medical Forum. https://doi.org/10.4414/fms.2012.01378
221. Macbeth, A. N., Tomlinson, J., Messenger, A. G., Moore-Millar, K., Michaelides, C., Shipman, A. R., Kassim, J., Brockley, J., Szczecińska, W., Farrant, P., Robinson, R., Rodgers, J., Chambers, J. N., Upadhyaya, S., & Harries, M. (2018). 设立针对脱发(斑秃除外)预防、诊断和治疗的研究问题并安排优先顺序:脱发优先设定合作伙伴关系. British Journal of Dermatology. https://doi.org/10.1111/bjd.16308
222. MacCulloch, T., & Lowenstein, L. F. (2009). Do the Causes of Psychotic Symptoms Matter?. Issues in Mental Health Nursing. https://doi.org/10.1080/01612840903177464
223. MacCulloch, T., & Lowenstein, L. F. (2009). Do the Causes of Psychotic Symptoms Matter?. Issues in Mental Health Nursing. https://doi.org/10.3109/01612840903177464
224. Macedo, V. D., & Hoshi, Y. (2017). Crise tireotóxica como diagnóstico diferencial de doença psquiátrica: Relato de Caso / Thyrotoxic crisis in the differential diagnosis of psychiatric disorders: Case Report.
225. Mackay, C. E. (2023). Trichotillomania: a perspective synthesised from neuroscience and lived experience. BMJ Mental Health. https://doi.org/10.1136/bmjment-2023-300795
226. Mackel, C. E., Alterman, R. L., Buss, M. K., Reynolds, R. M., Fox, W. C., Spiotta, A. M., Davis, R. B., & Stippler, M. (2022). Moral Distress and Moral Injury Among Attending Neurosurgeons: A National Survey. Neurosurgery. https://doi.org/10.1227/neu.0000000000001921
227. Madison, L., & LaFranchi, S. (2018). Non-thyroidal Illness Syndrome. Pediatric Endocrinology. https://doi.org/10.1007/978-3-319-73782-9_19
228. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
229. Mainka, T., Ganos, C., Kühn, A. A., & Marcelino, A. L. D. A. (2020). Tiefe Hirnstimulation als Therapieoption für das Tourette-Syndrom. Nervenheilkunde. https://doi.org/10.1055/a-1100-4768
230. Malik, P., Verma, A., & Panghal, P. (2024). Unravelling The Cause and Consequences of Post Traumatic Stress Disorder: A Comprehensive Review. International Journal For Multidisciplinary Research. https://doi.org/10.36948/ijfmr.2024.v06i04.24769
231. Manschreck, T. C. (1996). Delusional disorder: the recognition and management of paranoia.. PubMed.
232. Marcel, C., & Tranchant, C. (2012). Prise en charge thérapeutique des mouvements anormaux. Médecine thérapeutique. https://doi.org/10.1684/met.2012.0358
233. Margules, D. L. (2015). The Vulnerability of Athletes to Brain Degeneration due to Chronic Traumatic Encephalopathy (CTE) Caused by Repetitive, Mild-traumatic Brain Injuries in Football and other Sports. Acta Psychopathologica. https://doi.org/10.4172/2469-6676.100021
234. Marková, J., & Linhartová, A. (2010). Léčba migrény během gravidity a kojení. Neurologie pro praxi.
235. Martinez, J. D. (2020). El paciente con cefalea por uso excesivo de medicamentos en urgencias. Acta neurológica colombiana. https://doi.org/10.22379/24224022314
236. Martínez, A. A. B. (2019). A Way of Bridging the Gap between Psychological Treatments and Antidepressant Medication. International Journal of Depression and Anxiety. https://doi.org/10.23937/ijda-2017/1710010
237. Martínez-Aguayo, J. C., Middleton, F., Nahuelcura, K., Arancibia, M., Meza-Concha, N., Sepúlveda, E., Gepp, A., Escobar, R., & Madrid, E. (2017). Caracterización fenomenológica de las conductas repetitivas impulsivas orientadas hacia el cuerpo y el trastorno por excoriación en estudiantes universitarios. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272017000400221
238. Masel, B. E., Zgaljardic, D. J., & Forman, J. (2015). Post-traumatic hypopituitarism and fatigue. Neuropsychological Rehabilitation. https://doi.org/10.1080/09602011.2015.1125374
239. McElroy, S. L., Hudson, J. I., Pope, H. G., & Keck, P. E. (1991). Kleptomania: clinical characteristics and associated psychopathology. Psychological Medicine. https://doi.org/10.1017/s0033291700014690
240. McKenzie, B., Walker, T., & Chin, C. (2018). Prevalence of Burnout in Bahamian Health Care Personnel. Journal of Occupational and Environmental Medicine. https://doi.org/10.1097/jom.0000000000001383
241. Mehta, S. A. J., Epstein, J. B., & Greene, C. S. (2006). Recognition and management of headache.. PubMed.
242. Melville-Drewes, A. (2018). Posttraumatische Verbitterungsstörung, Burn-out ... – arbeitsplatzbezogene psychische Störungen in der amtsärztlichen Begutachtung. Das Gesundheitswesen. https://doi.org/10.1055/s-0038-1639183
243. Mendelevich, В. D., Sivolap, Y. P., & Lubyanko, I. A. (2017). RESIDUAL PSYCHOTIC DISORDER AS A CONSEQUENCE OF PSYCHOSTIMULANTS USE OR SCHIZOPHRENIA? (CLINICAL ANALYSIS). Neurological Bulletin. https://doi.org/10.17816/nb14078
244. Merlín, E. P.-R., González‐Forteza, C., Lira, L. R., & Tapia, J. A. J. (2007). Trastorno por estrés postraumático en pacientes con lesiones no intencionales producidas en accidentes de tránsito. Salud Mental.
245. Miguel, A. P., & Braga, A. R. (2015). TRICOTILOMANIA E SUAS CARACTERISTICAS.
246. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
247. Minvielle, S., & Clervoy, P. (2003). [Traumatic repetition syndrome].. PubMed.
248. Mitropoulos, G. B. (2021). Being psychotic is not necessarily being ill: Psychotic continuum and the relevance of lacanian psychoanalytic approach. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2127
249. Mocanu, M., Vâță, D., Alexa, A. I., Iancu, E., Solovăstru, D., Pătrașcu, A., & Solovăstru, L. G. (2023). Alopecia – focus on negative emotional impact. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2023.2.05
250. Moch, S. (2011). Dysthymia: more than "minor".
251. Moch, S. (2011). Dysthymia: more than “minor” depression. South African Pharmaceutical Journal.
252. Moldofsky, H., & Crisp, A. H. (1965). A Psychosomatic Study of Writer's Cramp. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.111.478.841
253. Mollasadeghi, A., Mehrparvar, A. H., Atighechi, S., Davari, M. H., Shokouh, P., Mostaghaci, M., & Bahaloo, M. (2013). Sensorineural Hearing Loss after Magnetic Resonance Imaging. Case Reports in Radiology. https://doi.org/10.1155/2013/510258
254. Molloy, S., Batchelor, G., Mallett, P., Thompson, A., Bourke, T., Fitzsimons, A., & Richardson, J. (2020). Fifteen-minute consultation: Severe traumatic brain injury in paediatrics. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2019-318246
255. Mondragon, S. (1991). Controle thalamique de l'epilepsie partielle motrice chez le singe porteur d'un foyer cortical chronique.
256. Monti, J. M., & Pandi‐Perumal, S. R. (2014). Role of zolpidem in the management of primary and comorbid insomnia. https://doi.org/10.2217/fmeb2013.13.146
257. Moreno, M. A. G., Torres, M. Á. G., & Gaviria, M. (2015). Trastornos afectivos estacionales, "winter blues". Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352015000200010
258. Morin, J. W. (2010). Exhibitionism. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0328
259. Moshé, S. L., & Galanopoulou, A. S. (2018). Commentary on Schotte et al. “Development of temporal lobe epilepsy during maintenance electroconvulsive therapy: A case of human kindling?”. Epilepsia Open. https://doi.org/10.1002/epi4.12296
260. Mulana, V. A. S. (2020). POTENSI PENERAPAN MHEALTH DALAM MENANGGULANGI PTSD (POST TRAUMATIC STRESS DISORDER) PASCA BENCANA ALAM DI INDONESIA, SEBUAH REVIEW NON-SISTEMATIK.
261. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
262. Nadeem, R., Ahmad, K., & Anwar, M. I. (2019). Dermatitis neglecta: a frequent misdiagnosis. Journal of Pakistan Association of Dermatology.
263. Naidu, B. M. (2016). Drug Abuse in India. International journal of research in social sciences.
264. Nambudiri, D. E., Meyers, B. S., & Young, R. C. (1991). Delayed Recovery From Lithium Neurotoxicity. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198879100400108
265. Narayanan, D. H., Ranjan, A., Asirvatham, A. R., & Mahadevan, S. (2024). A Young Man with a Limp—Hypothyroidism Presenting with Slipped Capital Femoral Epiphysis. Indian Journal of Endocrinology and Metabolism. https://doi.org/10.4103/ijem.ijem_406_23
266. Negrete, M. G. S. (2011). Síntomas inespecíficos y estrés: una relación posible.
267. Nejad, A. F., Ranjbar, E., Nejad, H. F., Mohammadi, R. S., Rajabi, Z., Mostafavi, S., Anari, P. Y., & Bidaki, R. (2015). Trichotillomania (Hair-Pulling) in a 4.5-Year-Old Girl. Thrita. https://doi.org/10.5812/thrita.31376
268. Nemeczek, S., MERKISZ, K., Walczak, K., Walczak, P., Zdun, S., Grzybowski, J., Marciniak, A., Grzywna, N., JASKUŁA, K., & ORŁOWSKI, W. (2023). Trichotillomania – therapeutic possibilities. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2023.13.02.029
269. Nguyen, M., & Tharani, S. (2013). Trichotillomania in a 7 year old girl. Archives of Psychiatry and Psychotherapy. https://doi.org/10.12740/app/19144
270. Nieto-Pico, A. M., Rueda-Vargas, A., & Mora-Bautista, V. M. (2019). Trastornos por tics en niños: un caso con retraso diagnóstico. CES Medicina. https://doi.org/10.21615/cesmedicina.33.2.6
271. Nikolaus, S. (2011). Loneliness and Emptiness - Reorientation Syndrome after Traumatic Brain Injury Mechanism: Access and Solutions to This Underestimated Problem After Traumatic Brain Injury. NATO science for peace and security series. Sub-series E, Human and societal dynamics. https://doi.org/10.3233/978-1-60750-797-0-187
272. Nosek, M. A., & Howland, C. A. (1998). Abuse and Women with Disabilities.
273. Nubli, M. A. (2019). Depresi Pada Penderita Cedera Kepala. https://doi.org/10.35816/jiskh.v10i2.151
274. Olszewska, A., Daktera-Micker, A., Cieślińska, K., Firlej, E., & Biedziak, B. (2017). Auto-aggressive behavior in dental patients. Journal of Medical Science. https://doi.org/10.20883/jms.2017.210
275. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
276. Osterman, J. E., Erdos, B. Z., Oldham, M., & Ivkovic, A. (2010). Antidepressant Treatments in PTSD. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-435-7_7
277. Oviedo, H. E. C., Andrade, B. A., Nogales, J. R. D., & Apaza, G. S. (2015). SÍNDROME DE CUTTING (AUTOLESIONISMO). Revista de Investigación e Información en Salud. https://doi.org/10.52428/20756208.v10i25.542
278. O’Connell, C., Reeder, E. L., Caceres, R. A., Collins, S. M., Chilton, K. Q., Gudelsky, G. A., & Robson, M. J. (2022). Closed Head Traumatic Brain Injury Drives Protracted Inflammation and Remodeling of Serotonergic Architecture in the Dorsal Raphe Nucleus. The FASEB Journal. https://doi.org/10.1096/fasebj.2022.36.s1.r4884
279. O’Connor, E., Tompson, M. C., & Miklowitz, D. J. (2015). Relational Problems. Psychiatry. https://doi.org/10.1002/9781118753378.ch86
280. O’Neil-Page, E., Anderson, P. R., & Dean, G. E. (2015). Fatigue. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244330.003.0001
281. O’Sullivan, R., Keuthen, N. J., Christenson, G., Mansueto, C. S., Stein, D. J., & Swedo, S. E. (1997). Trichotillomania: behavioral symptom or clinical syndrome? [clinical conference]. American Journal of Psychiatry. https://doi.org/10.1176/ajp.154.10.1442
282. Pacan, P., Kantorska-Janiec, M., & Kiejna, A. (1999). [Trichotillomania].. PubMed.
283. Pagnin, D., Queiroz, V. D., Filho, M. A. D. O., Gonzalez, N. V. A., Salgado, A. E. T., Oliveira, B. C. E., Lodi, C. S., & Melo, R. M. D. S. (2013). Burnout and career choice motivation in medical students. Medical Teacher. https://doi.org/10.3109/0142159x.2013.769673
284. Palacios-Sánchez, L., Botero-Meneses, J. S., Pachón, R., Piñeros-Hernández, L. B., Triana-Melo, J. D. P., & Rodríguez, S. G. R. (2018). Stendhal syndrome: a clinical and historical overview. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/0004-282x20170189
285. Pandya, D., Shinkar, D. M., & Saudagar, R. B. (2016). Kleptomania: An overview. Asian Journal of Pharmacy and Technology. https://doi.org/10.5958/2231-5713.2016.00017.9
286. Panwar, M., & Sankhala, J. (2023). A Successful Case Study on Ayurvedic Management of Hypothyroidism. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2023.49999
287. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
288. Parmet, S. (2003). Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2466
289. Parmet, S., Burke, A. E., & Glass, R. M. (2006). Insomnia. JAMA. https://doi.org/10.1001/jama.295.24.2952
290. Parmet, S., Lynm, C., & Glass, R. M. (2003). Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2602
291. Pashov, A. (2018). Paradigm shift in rehabilitation of long-standing Bell’s palsy during later stages of recovery. Fundamental and applied researches in practice of leading scientific schools.
292. Paulus, W. J., Reimers, C. D., & Steinhoff, B. J. (2000). Dystonien (unwillkürliche Muskelbewegungen). Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57726-0_16
293. Paw, H., & Shulman, R. (2014). Management of status epilepticus. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781316182673.042
294. Pechnick, R. N., Cunningham, K. A., & Danovitch, I. (2014). Hallucinogen-Related Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg51
295. Perente, M. A., Ferreira, T. G., & Bucci, T. (2015). TRANSTORNO OBSESSIVO COMPULSIVO: RELATO DE EXPERIÊNCIA. INVESTIGAÇÃO. https://doi.org/10.26843/investigacao.v14i5.1133
296. Perington, M. R., Smith, C. A., & Schillerstrom, J. E. (2019). Decisional Capacity and Personality Disorders: Substantially Unable or Substantially Unwilling?. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.14219
297. Perman, M. J. (2024). When Should I Suspect and How Do I Manage Hair Pulling (Trichotillomania)?. CRC Press eBooks. https://doi.org/10.1201/9781003523628-53
298. Perry, A., Graffeo, C. S., Peris‐Celda, M., Carlstrom, L. P., Kleinstern, G., Carlson, M. L., & Link, M. J. (2020). Cannot Stop, Will Not Stop: Assessing the Impact of Tinnitus on Patient-Reported Hearing-Related Quality-of-Life Outcomes in Vestibular Schwannoma. Journal of Neurological Surgery Part B Skull Base. https://doi.org/10.1055/s-0040-1702463
299. Phillips, K. A., & Stein, D. J. (2015). Obsessive–Compulsive and Related Disorders: Body Dysmorphic Disorder, Trichotillomania (Hair‐Pulling Disorder), and Excoriation (Skin‐Picking) Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch58
300. Phillips, K. A., O’Sullivan, R., & Pope, H. G. (1997). Muscle Dysmorphia. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v58n0806a
301. Piagkou, M., Demesticha, T., Piagkos, G., Georgios, A., & Panagiotis, S. (2010). Lingual Nerve Entrapment in Muscular and Osseous Structures. International Journal of Oral Science. https://doi.org/10.4248/ijos10063
302. Piwuna, C. G., Makput, D. M., & Wakil, M. A. (2015). Persistent delusional disorder in a 32 year old male. Highland Medical Research Journal.
303. PM, A., Anjumol, M., & Jithesh, M. (2023). Schizophrenia - An Ayurvedic Management. International Journal of Ayurveda and Pharma Research. https://doi.org/10.47070/ijapr.v11i12.3056
304. Polo‐Kantola, P., & Erkkola, R. (2004). Sleep and the menopause. The Journal of the British Menopause Society. https://doi.org/10.1258/1362180042721076
305. Poot, F. (2004). [Psychological consequences of chronic hair diseases].. PubMed.
306. Poot, F. (2004). Le retentissement psychologique des pathologies chroniques du cheveu Psychological consequences of chronic hair diseases.
307. Poot, F. (2004). Le retentissement psychologique des pathologies chroniques du cheveu. Revue Medicale de Bruxelles.
308. Porter, K., & Lee, C. (2007). Suspension trauma. Emergency Medicine Journal. https://doi.org/10.1136/emj.2007.046391
309. Powers, S. W., Gilman, D. K., & Hershey, A. D. (2006). Headache and Psychological Functioning in Children and Adolescents. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2006.00583.x
310. Pratama, F. I. (2018). TERAPI KOMBINASI PIJAT SWEDIA, TUINA DAN NUTRISI DAUNKELOR (Moringa oleifera) PADA PENGOBATAN INSOMNIA.
311. Prough, D. S., & DeWitt, D. S. (1996). Head trauma and brain resuscitation. Current Opinion in Anaesthesiology. https://doi.org/10.1097/00001503-199604000-00013
312. Queiroz, R., Pelegrina, M., Fontes, D., Testa, J. R. G., & Borghi, F. A. N. (2024). The impact of occlusal plane rehabilitation on the face of a patient with traumatic peripheral facial paralysis by Timpanic jugular tumor – case report. Jaw Functional Orthopedics and Craniofacial Growth. https://doi.org/10.21595/jfocg.2024.23727
313. Ramirez, E. A., Maldonado, J., Arce, B., Díaz, M. J. S., & Varon, J. A. T. (2023). An Undervalued Diagnosis: Post-Traumatic Stress Disorder in the Perinatal Period: A Case Report. International Journal of Medical Students. https://doi.org/10.5195/ijms.2023.2386
314. Rani, S., & Saini, D. S. (2015). Organizational Stress in Relation to Job Satisfaction and General Health of Professional Women. International journal of education and management studies.
315. Reese, R., & Volkmann, J. (2014). Deep brain stimulation for dystonia. https://doi.org/10.2217/ebo.13.97
316. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
317. Rempel, D., Hegmann, K. T., & Meister, R. (2018). 1632f Varied criteria for work-related upper extremity disorders in united states. https://doi.org/10.1136/oemed-2018-icohabstracts.732
318. Ricciardelli, R., & Johnston, M. S. (2022). Police Mental Health and Wellness. Oxford Research Encyclopedia of Criminology and Criminal Justice. https://doi.org/10.1093/acrefore/9780190264079.013.752
319. Riskina, C. N. (2020). HUBUNGAN GANGGUAN PSIKOTIK SKIZOFRENIA PARANOID TERHADAP KEHILANGAN GIGI SEBAGIAN PADA PASIEN DI RUMAH SAKIT JIWA BANDA ACEH. ETD Unsyiah.
320. Rizk, M. S., Nader, E. A., Karam, C., & Ayoub, C. M. (2011). Low back pain as perceived by the pain specialist.. PubMed.
321. Rnic, K., & Dozois, D. J. A. (2020). Depression. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781118970843.ch197
322. Rochira, V., Carani, C., & Granata, A. R. M. (2022). Management of Sexual Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198870197.003.0193
323. Rodriguez, C. P., Budur, K., & Foldvary‐Schaefer, N. (2007). Advances in treating insomnia.. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.74.4.251
324. Rodríguez, S. P. G., & Maestre, M. Á. M. (2006). Menopausia y trastornos psicoafectivos. Ginecología y obstetricia clínica/Ginecología y obstetricia clínica.
325. Roessner, V., & Rothenberger, A. (2014). Tic Disorders. https://doi.org/10.1007/978-3-7091-1501-5_27
326. Rogers, M. T., & Clyburn, P. (2004). Anaesthesia and myotonic dystrophy. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198527824.003.0008
327. Rosemberg, F. K., & Ramírez, N. O. (2017). Desorden en el área Física en infantes y adolescentes. Boletín Científico de la Escuela Superior Atotonilco de Tula. https://doi.org/10.29057/esat.v4i7.2195
328. Ross, M. (1951). A psychosomatic approach to the climacteric.. PubMed.
329. Rothman, M. S., Arciniegas, D. B., Filley, C. M., & Wierman, M. E. (2007). The Neuroendocrine Effects of Traumatic Brain Injury. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.2007.19.4.363
330. ROY, R., Kumar, S. P., & Kishor, M. (2022). A Case of Trichotillomania With Comorbid Depression And Anxiety. Digital Journal of Clinical Medicine. https://doi.org/10.55691/2582-3868.1004
331. Roychoudhury, A. (2018). Muscle Tension Dysphonia—The Untold Story. International Journal of Phonosurgery & Laryngology. https://doi.org/10.5005/ijopl-8-1-iv
332. Rubin, J. N. (2020). HEALTH EFFECTS OF COASTAL DISASTERS AFTER THE WATER RECEDES. Abstracts with programs - Geological Society of America. https://doi.org/10.1130/abs/2020am-350916
333. Ruiz, B. M. C. (2017). Influencia de la fatiga en la calidad de movimiento de personas con lesión medular.
334. Saad, M. A. E., & Kamel, O. M. (2019). Childhood-Onset Fluency Disorder (Stuttering): An Interruption in The Flow of Speaking. International Journal of Psycho-Educational Sciences.
335. Saleem, S., Mohsin, M. A., Khan, K. Z., & Sherani, F. (2019). Trichotillomania: A Problem Related with Depressive Mood and its Follow-up - A Case Study.
336. Sam, S. P., Varghese, J. J., & Kallivayalil, R. A. (2019). Religious delusions: it’s importance in psychiatry and a case report. Kerala Journal of Psychiatry. https://doi.org/10.30834/kjp.31.2.2018.149
337. Sandoval-Munoz, C. P., & Haidar, Z. S. (2021). Neuro-Muscular Dentistry: the “diamond” concept of electro-stimulation potential for stomato-gnathic and oro-dental conditions. Head & Face Medicine. https://doi.org/10.1186/s13005-021-00257-3
338. Sansone, R. A., & Sansone, L. A. (2010). Medically Unexplainable Somatic Symptoms: A Coat With Many Psychiatric Colors. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00879gre
339. Santos, D. S. D. O. F., & Vivan, R. H. F. (2018). Tratamento farmacológico da esclerose múltipla. Revista Terra & Cultura: Cadernos de Ensino e Pesquisa.
340. Sarris, A. B., Nakamura, M. C., Fernandes, L. G. R., Staichak, R. L., Pupulim, A. F., & Sobreiro, B. P. (2016). Pathophysiology, evaluation and treatment of erectile dysfunction: review article. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v95i1p18-29
341. Satoh‐Kuriwada, S., Shoji, N., Kawai, M., Uneyama, H., Kaneta, N., & Sasano, T. (2009). Hyposalivation Strongly Influences Hypogeusia in the Elderly. JOURNAL OF HEALTH SCIENCE. https://doi.org/10.1248/jhs.55.689
342. Savvopoulos, S. (2006). Red or Grey Angel. Revue française de psychosomatique.
343. Schildkrout, B. (2011). Characteristics That Make Somatic Diseases Difficult to Detect. https://doi.org/10.1002/9781118083598.ch3
344. Schils, S., & Isbell, D. (2015). The whole horse approach to equine physical rehabilitation: the biomechanical view. https://doi.org/10.3920/978-90-8686-818-6_5
345. Schindler‐Gmelch, L., Capito, K., Steudte‐Schmiedgen, S., Kirschbaum, C., & Berking, M. (2023). Hair Cortisol Research in Posttraumatic Stress Disorder - 10 Years of Insights and Open Questions. A Systematic Review. Current Neuropharmacology. https://doi.org/10.2174/1570159x21666230807112425
346. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
347. Schonfeld, I. S., Bianchi, R., & Palazzi, S. (2018). What is the difference between depression and burnout? An ongoing debate.. PubMed. https://doi.org/10.1708/2954.29699
348. Schreiber, L. R., Odlaug, B. L., & Grant, J. E. (2011). Diagnosis and treatment of trichotillomania. Neuropsychiatry. https://doi.org/10.2217/npy.11.8
349. Schrock, L. E., Xie, T., & Barton, B. (2016). None. https://doi.org/10.1002/9781118474075.ch7
350. Seidman, S. N. (2003). Testosterone Deficiency and Mood in Aging Men: Pathogenic and Therapeutic Interactions. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622970309167905
351. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
352. Shamanuru, L. G., Doddamane, V. B., & Preeti, V. (2021). Cockayne syndrome, xeroderma pigmentosa: a rare case report. International Journal of Contemporary Pediatrics. https://doi.org/10.18203/2349-3291.ijcp20210666
353. Sharpless, B. A., & Zimmerman, J. (2016). Exploding Head Syndrome. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780190245863.003.0004
354. Sharquie, K. E., & Al-Jaralla, F. A. (2020). Trichotillomania is chronic obsessive compulsive disease with a diagnostic hair loss patterns. American Journal of Dermatological Research and Reviews. https://doi.org/10.28933/ajodrr-2019-12-1505
355. Sheikh, A., & Godil, A. (2024). The Psychological Impact of Trichotillomania. Journal of the Osteopathic Family Physicians of California. https://doi.org/10.58858/030104
356. Shenefelt, P. D. (2024). Hypnosis for Skin Disorders. Routledge eBooks. https://doi.org/10.4324/9781003449126-55
357. Shkembi, A., Skenderi, E., Imeraj, F., Kuneshka, N., Xhelili, G., & Durma, A. (2023). A case of sexual abuse and art therapy. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2023.18.1.0566
358. Shoenfeld, N., Rosenberg, O., Kotler, M., & Dannon, P. N. (2012). Tricotillomania: pathopsychology theories and treatment possibilities.. PubMed.
359. Shomanbayeva, A., & Bazhan, T. (2018). On the problem of differentiation of mental burnout syndrome and chronic fatigue syndrome.
360. Siddiqui, J. A., & Qureshi, S. F. (2018). A Synopsis of Body Focused Repetitive Behavior.
361. Sigall, D. A., Mauricio, P. C., Alemán, P. G., Memije, M. E. V., & Arenas, R. (2010). Tricotilomanía. Una entidad psicodinámica.
362. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
363. Silva, T. D. O., Leite, J. R., Bezerra, W. D. S. P., Lima, M. B. L. D., & Fiorin, P. M. (2017). A DEPRESSÃO NA TERCEIRA IDADE:RELATO DE EXPERIÊNCIA DE UMA ATIVIDADE EDUCATIVA.
364. Sinaga, T. S. (2020). Terapi Latihan Pada Motor Delayed Akibat Hipotiroid di Rumah Sakit Efarina Etaham Berastagi Tahun 2016. 2-TRIK TUNAS-TUNAS RISET KESEHATAN. https://doi.org/10.33846/2trik10311
365. Singh, P. K. (2015). Psychogenic Headache in School Going Children. Indian Journal of Health and Wellbeing.
366. Singh, P. S. J., Azman, A., & Zain, R. M. (2022). Caregiver Stress in Dealing with Traumatic Brain Injury Family Members. Asian Social Work Journal. https://doi.org/10.47405/aswj.v7i1.196
367. Singh, P., Gehlawat, P., Gupta, R., & Soni, S. (2015). A rare case of trichotillomania with antisocial personality disorder. DOAJ (DOAJ: Directory of Open Access Journals).
368. Singh, S., & Vats, A. (2020). Impact of physiological and psychological stress on students. Deleted Journal.
369. Slagle, D., & Martin, T. A. (1991). Trichotillomania.. PubMed.
370. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
371. Soares, E. B., Pires, J. B., Menezes, M. D. A., Santana, S. K. S. D., & Fraga, J. (2010). Fonoaudiologia X ronco/apneia do sono. Revista CEFAC. https://doi.org/10.1590/s1516-18462010000200019
372. Solanki, G. A., Gatrad, A. R., & Sheikh, A. (2014). Baby with an abnormal head. BMJ. https://doi.org/10.1136/bmj.f7609
373. Sonderen, A. V., Laat, K. F. D., & Rijntjes, E. (2013). [Gustatory loss: causes, consequences and treatment].. PubMed.
374. Soto, P. A. H., & Alfonso, J. B. Z. (2015). Some specificities regarding the suicidal behavior.
375. Sotos, J. G. (2015). “What an Affliction”: Mary Todd Lincoln’s Fatal Pernicious Anemia. Perspectives in biology and medicine. https://doi.org/10.1353/pbm.2015.0034
376. Soundary, S., & Thomas, J. (2024). Trichotillomania: A case report and review of the literature. Our Dermatology Online. https://doi.org/10.7241/ourd.20243.9
377. Souza, W. I. T., Oliveira, G. P. R. D., Zilch, P. I. B., Jesus, S. C. S. D., & Grunbaum, S. (2024). Estimulação cerebral profunda como abordagem terapêutica em pacientes que sofrem de transtorno depressivo maior. Cuadernos de Educación y Desarrollo. https://doi.org/10.55905/cuadv16n2-ed.esp.118
378. Spier, S. J. (2006). Hyperkalemic Periodic Paralysis: 14 Years Later.
379. Sporns, P. B., Heermann, P., Burg, M., Molina, E. S., & Cnyrim, C. (2015). Zephalozele der Felsenbeinspitze: seltene Ursache einer Trigeminusneuralgie. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://doi.org/10.1055/s-0035-1553270
380. Srivastav, D., & Singh, T. B. (2016). Comorbidity Issues and Treatment in Chronic Mental Illness. Advances in psychology, mental health, and behavioral studies (APMHBS) book series. https://doi.org/10.4018/978-1-5225-0519-8.ch005
381. Srivastava, A., Srivastava, S., & Srivastava, N. (2015). Hair Disorders, Treatment and Care: an Overview.
382. Stanescu, I., & Vasilescu, M. (2023). THE CONTRIBUTION OF PHYSICAL THERAPEUTIC EXERCISES TO THE IMPROVEMENT OF MUSCLE IMPAIRMENT CAUSED BY MUSCULAR DYSTROPHY. The Annals of Dunarea de Jos University of Galati Fascicle XV Physical Education and Sport Management. https://doi.org/10.35219/efms.2023.1.20
383. Stanetić, K. (2018). Burnout Syndrome in Family Physicians – Experiences from Bosnia and Herzegovina. Psychology and Mental Health Care. https://doi.org/10.31579/2637-8892/027
384. Stecher, S. (2018). Understanding Disorders of Mood exploring the differences between Disorders of Thought and Mood.
385. Stein, D. J., Chamberlain, S. R., & Fineberg, N. (2006). An A-B-C Model of Habit Disorders: <i>Hair-Pulling, Skin-Picking, and Other Stereotypic Conditions</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900014978
386. Stein, D. J., Mullen, L. S., Islam, M. N., Cohen, L. J., Caria, C. M. D., & Hollander, E. (1995). Compulsive and Impulsive Symptomatology in Trichotillomania. Psychopathology. https://doi.org/10.1159/000284923
387. Steinhausen, H., & Gillberg, C. (2006). Brain disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543807.002
388. Stemberger, R. M. T., Stein, D. J., & Mansueto, C. S. (2003). Behavioral and Pharmacological Treatment of Trichotillomania. Brief Treatment and Crisis Intervention. https://doi.org/10.1093/brief-treatment/mhg025
389. Stroev, Y. I., Sobolevskaya, P. A., Churilov, L. P., & Utehin, V. J. (2017). The role of hypocalcemia and vitamin D3 in pathogenesis of phobias in chronic autoimmune Hashimoto’s thyroiditis. Pediatrician (St Petersburg). https://doi.org/10.17816/ped8439-42
390. St⊘ylen, I. J. (1996). Treatment of Trichotillomania by Habit Reversal. Scandinavian Journal of Behaviour Therapy. https://doi.org/10.1080/16506079609456020
391. Suarte, L. A. M., Oliveira, R. F. L. D., Maia, D. C., Schneiberg, S., & Santana, L. S. (2014). Tratamento fisioterapêutico na criança hipotônica. Semana de Pesquisa e Extensão da Universidade Tiradentes - SEMPESq-SEMEX.
392. Sumiyoshi, T., Matsuoka, T., & Kurachi, M. (2012). Role for Pituitary Neuropeptides in Social Behavior Disturbances of Schizophrenia. InTech eBooks. https://doi.org/10.5772/52326
393. Sutar, R., Rajan, A., & Siddiqui, F. (2022). Rare presentation of Trichotillomania in an elderly with sensory impairments: A case report with diagnostic and therapeutic challenges. Psychiatry Research Case Reports. https://doi.org/10.1016/j.psycr.2022.100051
394. Suzuki, H. (2013). [Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs].. PubMed.
395. Sánchez-Narváez, F. (2018). Síndrome de burnout. Editorial Académica Española eBooks.
396. Tartaglia, N., Howell, S., Sutherland, A., Wilson, R. L., & Wilson, L. (2010). A review of trisomy X (47,XXX). Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-5-8
397. Tartaglia, N., Howell, S., Sutherland, A., Wilson, R. L., & Wilson, L. (2010). Reviewof trisomy X (47,XXX).
398. Tedyanto, E. H., Adnyana, I. M. O., & Widyadharma, I. P. E. (2023). Tension-type Headache and Migraine as Manifestations of Chronic Post-Traumatic Headache. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v50i2.528
399. Telegdy, E. (2009). Trichotillomania. Orvosi Hetilap. https://doi.org/10.1556/oh.2009.28700
400. Tickner, N., Apps, J., Keady, S., & Sutcliffe, A. (2012). An overview of drug therapies used in the treatment of dystonia and spasticity in children. Archives of Disease in Childhood Education & Practice. https://doi.org/10.1136/archdischild-2011-301170
401. Tiling, E. (1975). [Trichotillomania as a phenomenon of unexplained loss of hair in childhood (author's transl)].. PubMed.
402. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
403. Torales, J., & Ortíz, B. D. M. (2016). Una pequeña puesta al día sobre la tricotilomanía. Our Dermatology Online. https://doi.org/10.7241/ourd.20164.127
404. Torales, J., Diáz, N. R., Ventriglio, A., Castaldelli-Maia, J. M., Barrios, I., García, Ó., Navarro, R., González, I., O’Higgins, M., & Jafferany, M. (2020). <scp>Hair‐pulling</scp> disorder (Trichotillomania): Etiopathogenesis, diagnosis and treatment in a nutshell. Dermatologic Therapy. https://doi.org/10.1111/dth.14366
405. Travers, P. L. (1999). Autonomic Dysreflexia: A Clinical Rehabilitation Problem. Rehabilitation Nursing. https://doi.org/10.1002/j.2048-7940.1999.tb01825.x
406. Trivedi, P. P., & Mistry, K. H. (2017). Trichotillomania: A Case Study. International Journal of Indian Psychology. https://doi.org/10.25215/0501.060
407. Tsze, D. S., & Chun, T. H. (2012). 377 Head Injury in Children.
408. Tugendhaft, P. (2004). [The follow-up of antiepileptic drugs].. PubMed.
409. Turgeon, S. A. (1991). Syndrome de fatigue chronique. Canadian Family Physician.
410. Turk, J., Graham, P. L., & Verhulst, F. C. (2007). Prevention and treatment. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199216697.003.0009
411. Upadhyaya, K. D. (2017). Stress Management For Good Physical And Mental Health. Journal of Psychiatrists Association of Nepal. https://doi.org/10.3126/jpan.v4i2.18321
412. Upton, D., & South, F. (2011). The Psychological Consequences of Wounds - a Vicious Circle that Should not be Overlooked.. Wounds UK.
413. Vaidya, V. A., Siuciak, J. A., Du, F., & Duman, R. S. (1999). Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience. https://doi.org/10.1016/s0306-4522(98)00289-9
414. Velayudha, V., Vasista, A., Tejasri, K., & Madhura, G. (2021). Biomedical Sleep Inducer. 2022 8th International Conference on Advanced Computing and Communication Systems (ICACCS). https://doi.org/10.1109/icaccs51430.2021.9441672
415. Venkatesh, S., & Stanley, P. (2018). Dystonia: A systemic review. World Journal of Pharmaceutical Sciences.
416. Venugopal, N., & Gopal, M. S. (2013). Migraine is a marker for systemic disease. Indian Journal of Ophthalmology. https://doi.org/10.4103/0301-4738.121094
417. Vera-Miquilena, E., Lysandrou, H., Yi, S. Y., Soghomonyan, S., & Lysandrou, P. J. (2024). Delayed Neuromuscular Recovery after General Anesthesia: A Case of Atypical Plasma Cholinesterase. Deleted Journal. https://doi.org/10.26420/austinjanesthesiaandanalgesia.2024.1120
418. Vicente, M. O., Gutiérrez, L. E. J. F., & Oves, M. I. R. (2011). ALCOHOLISMO CONSECUTIVO AL TRASTORNO DE PÁNICO. DOAJ (DOAJ: Directory of Open Access Journals).
419. Vicente, S. B., Tavares, M. B., & Siqueira, E. C. D. (2023). Síndrome de Tourette. Revista Eletrônica Acervo Médico. https://doi.org/10.25248/reamed.e12923.2023
420. Vicente-Herrero, M. T., Alberich, J., Torre, M. V. R. I. D. L., García, L. C., García, M. J. T., López‐González, Á. A., & Jiménez, E. A. (2014). Accidente de trabajo por crisis epiléptica y traumatismo craneoencefálico con resultado de muerte Una revisión desde la jurisprudencia y legislación en España. Acta neurológica colombiana.
421. Vliet, I. M. V. (1999). [A hidden compulsion].. PubMed.
422. Vlčková, A., Strejc, P., Sachl, J., Dreßler, J., & Vajtr, D. (2010). [Another mechanism of décollement].. PubMed.
423. Wahyuni, A., & Fr, C. (2020). Gangguan Mental Organik e.c. Epilepsi pada Laki-Laki Usia 17 Tahun : Laporan Kasus. Jurnal Medula.
424. Wahyuningsih, S., Nurun, N., Ainul, A., Rendra, R., & Dwiki, D. (2020). Relaksasi Nafas Dalam Terhadap Tingkat Kecemasan Pada Lansia Yang Menderita Hipertensi Di RT 03 RW 09 Kelurahan Slipi Palmerah Jakarta Barat. JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). https://doi.org/10.33024/jkpm.v3i2.3194
425. Wallace, D., & Cooper, J. (2015). Update on the management of post‑traumatic stress disorder. Australian Prescriber. https://doi.org/10.18773/austprescr.2015.017
426. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
427. Wesensten, N. J., & Balkin, T. J. (2013). The challenge of sleep management in military operations.. PubMed.
428. Widodo, Y. W. P., & Ambarini, T. K. (2024). A Case Study: Empty Chair Therapy for A Survivor of Suicide with Depression with Psychotic. Psikoborneo Jurnal Ilmiah Psikologi. https://doi.org/10.30872/psikoborneo.v12i2.14685
429. Witkowski, A., Schwartz, R. A., & Janniger, C. K. (2010). Trichotillomania: an important psychocutaneous disorder.. PubMed.
430. Woda, A., Dao, T., & Richard, C. G. (2009). Focus Article:: Steroid Dysregulation and Stomatodynia (Burning Mouth Syndrome). Journal of Oral & Facial Pain and Headache.
431. Wortzel, H. S., Brenner, L. A., & Silver, J. (2018). Traumatic Brain Injury. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy12
432. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
433. Xu, S.-Y., Li, Z.-X., Wu, X., Li, L., & Li, C. (2020). Frequency and Pathophysiology of Post-Seizure Todd’s Paralysis. Medical Science Monitor. https://doi.org/10.12659/msm.920751
434. Yadav, V., Gera, C., & Yadav, R. (2018). Evolution in Hemiplegic Management: A Review. International Journal of Health Sciences and Research.
435. Yamaguchi, T., Nomura, J., Nishikubo, M., Tsujimura, R., & Hatotani, N. (1975). Studies on Thyroid Therapy and Thyroid Function in Depressive Patients. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/j.1440-1819.1975.tb02339.x
436. Yang, Z., Wang, P., Morgan, D., Bruijnzeel, A. W., Lin, D., Pan, J., Lin, F., Strang, K. H., Selig, T. M., Pérez, P. D., Febo, M., Chang, B., Rubenstein, R., & Wang, K. (2015). Correction: Corrigendum: Temporal MRI characterization, neurobiochemical and neurobehavioral changes in a mouse repetitive concussive head injury model. Scientific Reports. https://doi.org/10.1038/srep15922
437. Yaramış, Ç. P., Demirtaş, B., ISSAUTIER, M. N., SAKA, S. U., Erdikmen, D. O., & Or, M. E. (2016). Sterotipik Davranış Bozukluğu Gösteren 17 Atın Homeopati ile Tedavisi. Kafkas Universitesi Veteriner Fakultesi Dergisi. https://doi.org/10.9775/kvfd.2016.15418
438. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
439. Yélamos, C. (2020). The Psychological Approach: The Healing Power of Image and Comprehensive Assistance to Cancer Patients. CRC Press eBooks. https://doi.org/10.1201/9780203728888-6
440. Zairinal, R. A. (2022). Editorial. Majalah Kedokteran Neurosains Perhimpunan Dokter Spesialis Saraf Indonesia. https://doi.org/10.52386/neurona.v39i3.427
441. Zalsman, G., Sever, J. L., & Munitz, H. A. (1999). Hair loss associated with paroxetine treatment: a case report.. PubMed.
442. Zhao, X., Wang, S., Hong, X., Lu, S., Tang, S., Shen, Y., Feng, M., Guo, P., & Yu, F. (2021). A case of trichotillomania with bulimia: combined with N-acetylcysteine synergistic therapy. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-430592/v1
443. Zhban, E. S., Likhanov, M., Zakharov, I., Bezrukova, E. M., & Malykh, S. (2018). The Role of Mathematical and Trait Anxiety in Mental Fatigue: an EEG Investigation. Psychology in Russia State of Art. https://doi.org/10.11621/pir.2018.0406
444. Zhu, S., Luo, X., Li, Y.-F., Kurihara, H., & He, R. (2018). [Emotional stress-induced Shanghuo syndrome increases disease susceptibility].. PubMed. https://doi.org/10.19540/j.cnki.cjcmm.20180104.021
445. Zhu, Y., Han, G., & Li, S. (2019). Chronic Fatigue Stress and Sudden Death. IntechOpen eBooks. https://doi.org/10.5772/intechopen.88649